JP2002265977A - Perfume composition capable of activating sympathetic nerve - Google Patents
Perfume composition capable of activating sympathetic nerveInfo
- Publication number
- JP2002265977A JP2002265977A JP2001390141A JP2001390141A JP2002265977A JP 2002265977 A JP2002265977 A JP 2002265977A JP 2001390141 A JP2001390141 A JP 2001390141A JP 2001390141 A JP2001390141 A JP 2001390141A JP 2002265977 A JP2002265977 A JP 2002265977A
- Authority
- JP
- Japan
- Prior art keywords
- oil
- fragrance
- sympathetic nerve
- slimming
- ylang
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 69
- 230000002889 sympathetic effect Effects 0.000 title claims abstract description 44
- 210000005036 nerve Anatomy 0.000 title claims abstract description 26
- 230000003213 activating effect Effects 0.000 title claims abstract description 18
- 239000002304 perfume Substances 0.000 title abstract description 26
- 239000003921 oil Substances 0.000 claims abstract description 47
- 235000019198 oils Nutrition 0.000 claims abstract description 47
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims abstract description 42
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims abstract description 26
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 claims abstract description 24
- 235000008184 Piper nigrum Nutrition 0.000 claims abstract description 23
- 235000002566 Capsicum Nutrition 0.000 claims abstract description 22
- 239000006002 Pepper Substances 0.000 claims abstract description 22
- 235000016761 Piper aduncum Nutrition 0.000 claims abstract description 22
- 235000017804 Piper guineense Nutrition 0.000 claims abstract description 22
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 claims abstract description 22
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229960001948 caffeine Drugs 0.000 claims abstract description 21
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000010651 grapefruit oil Substances 0.000 claims abstract description 20
- -1 pinene Chemical compound 0.000 claims abstract description 18
- 239000010643 fennel seed oil Substances 0.000 claims abstract description 16
- 239000001276 artemisia dracunculus l. absolute Substances 0.000 claims abstract description 14
- 239000010630 cinnamon oil Substances 0.000 claims abstract description 14
- 239000001735 hyssopus officinalis l. herb oil Substances 0.000 claims abstract description 14
- 235000001510 limonene Nutrition 0.000 claims abstract description 14
- 229940087305 limonene Drugs 0.000 claims abstract description 14
- 239000010670 sage oil Substances 0.000 claims abstract description 14
- 240000007436 Cananga odorata Species 0.000 claims abstract description 13
- 239000010642 eucalyptus oil Substances 0.000 claims abstract description 13
- 229940044949 eucalyptus oil Drugs 0.000 claims abstract description 13
- 239000010648 geranium oil Substances 0.000 claims abstract description 13
- 235000019717 geranium oil Nutrition 0.000 claims abstract description 13
- 239000010649 ginger oil Substances 0.000 claims abstract description 13
- 239000010668 rosemary oil Substances 0.000 claims abstract description 13
- 229940058206 rosemary oil Drugs 0.000 claims abstract description 13
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000010634 clove oil Substances 0.000 claims abstract description 12
- 229960002903 benzyl benzoate Drugs 0.000 claims abstract description 11
- 239000003205 fragrance Substances 0.000 claims description 84
- 241000722363 Piper Species 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 3
- 230000006883 memory enhancing effect Effects 0.000 claims description 2
- 238000005452 bending Methods 0.000 claims 2
- 230000007087 memory ability Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 31
- 239000004863 Frankincense Substances 0.000 abstract description 8
- 241000717739 Boswellia sacra Species 0.000 abstract description 6
- 244000203593 Piper nigrum Species 0.000 abstract description 2
- 235000007571 Cananga odorata Nutrition 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 239000000284 extract Substances 0.000 description 29
- 238000009472 formulation Methods 0.000 description 27
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 239000000341 volatile oil Substances 0.000 description 17
- 235000019441 ethanol Nutrition 0.000 description 16
- 239000000796 flavoring agent Substances 0.000 description 13
- 235000011187 glycerol Nutrition 0.000 description 13
- 239000008213 purified water Substances 0.000 description 13
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 230000008035 nerve activity Effects 0.000 description 12
- 235000019634 flavors Nutrition 0.000 description 11
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 150000003943 catecholamines Chemical class 0.000 description 10
- 239000002738 chelating agent Substances 0.000 description 10
- 238000001256 steam distillation Methods 0.000 description 10
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 8
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 8
- 229920002125 Sokalan® Polymers 0.000 description 8
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 8
- 229960002748 norepinephrine Drugs 0.000 description 8
- 239000003755 preservative agent Substances 0.000 description 8
- 230000002335 preservative effect Effects 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- 206010005746 Blood pressure fluctuation Diseases 0.000 description 7
- 230000036772 blood pressure Effects 0.000 description 7
- 229960001631 carbomer Drugs 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 241000207923 Lamiaceae Species 0.000 description 6
- 240000000783 Origanum majorana Species 0.000 description 6
- 239000004359 castor oil Substances 0.000 description 6
- 235000019438 castor oil Nutrition 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 6
- 230000035943 smell Effects 0.000 description 6
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 5
- CDNNKGWZSNSADW-UHFFFAOYSA-N 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16,18,18,20,20-icosamethyl-1,3,5,7,9,11,13,15,17,19-decaoxa-2,4,6,8,10,12,14,16,18,20-decasilacycloicosane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 CDNNKGWZSNSADW-UHFFFAOYSA-N 0.000 description 5
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 5
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 210000003403 autonomic nervous system Anatomy 0.000 description 5
- 229940008099 dimethicone Drugs 0.000 description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 229940041616 menthol Drugs 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 5
- 210000002820 sympathetic nervous system Anatomy 0.000 description 5
- 230000002195 synergetic effect Effects 0.000 description 5
- 229940042585 tocopherol acetate Drugs 0.000 description 5
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 4
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 4
- 240000006927 Foeniculum vulgare Species 0.000 description 4
- 235000013719 Houttuynia cordata Nutrition 0.000 description 4
- 240000000691 Houttuynia cordata Species 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- 235000011203 Origanum Nutrition 0.000 description 4
- 102000008200 Uncoupling Protein 3 Human genes 0.000 description 4
- 108010021098 Uncoupling Protein 3 Proteins 0.000 description 4
- 239000000443 aerosol Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229960000735 docosanol Drugs 0.000 description 4
- 229940074052 glyceryl isostearate Drugs 0.000 description 4
- 229940075529 glyceryl stearate Drugs 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 235000011118 potassium hydroxide Nutrition 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 230000035488 systolic blood pressure Effects 0.000 description 4
- 239000000230 xanthan gum Substances 0.000 description 4
- 229920001285 xanthan gum Polymers 0.000 description 4
- 235000010493 xanthan gum Nutrition 0.000 description 4
- 229940082509 xanthan gum Drugs 0.000 description 4
- PSQYTAPXSHCGMF-BQYQJAHWSA-N β-ionone Chemical compound CC(=O)\C=C\C1=C(C)CCCC1(C)C PSQYTAPXSHCGMF-BQYQJAHWSA-N 0.000 description 4
- 235000007173 Abies balsamea Nutrition 0.000 description 3
- 240000007551 Boswellia serrata Species 0.000 description 3
- 241000195628 Chlorophyta Species 0.000 description 3
- 241000207199 Citrus Species 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 3
- 101000879758 Homo sapiens Sjoegren syndrome nuclear autoantigen 1 Proteins 0.000 description 3
- 244000018716 Impatiens biflora Species 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000206572 Rhodophyta Species 0.000 description 3
- 102100037330 Sjoegren syndrome nuclear autoantigen 1 Human genes 0.000 description 3
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 3
- 235000006886 Zingiber officinale Nutrition 0.000 description 3
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 239000003518 caustics Substances 0.000 description 3
- 235000020971 citrus fruits Nutrition 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 229940086555 cyclomethicone Drugs 0.000 description 3
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 235000008397 ginger Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000010666 rose oil Substances 0.000 description 3
- 235000019719 rose oil Nutrition 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- 239000001069 triethyl citrate Substances 0.000 description 3
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 3
- 235000013769 triethyl citrate Nutrition 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- SFEOKXHPFMOVRM-UHFFFAOYSA-N (+)-(S)-gamma-ionone Natural products CC(=O)C=CC1C(=C)CCCC1(C)C SFEOKXHPFMOVRM-UHFFFAOYSA-N 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 2
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 235000003826 Artemisia Nutrition 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000004857 Balsam Substances 0.000 description 2
- 235000003717 Boswellia sacra Nutrition 0.000 description 2
- 235000012035 Boswellia serrata Nutrition 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 2
- 240000000560 Citrus x paradisi Species 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- ZFMSMUAANRJZFM-UHFFFAOYSA-N Estragole Chemical group COC1=CC=C(CC=C)C=C1 ZFMSMUAANRJZFM-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 241000208690 Hamamelis Species 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 102220547770 Inducible T-cell costimulator_A23L_mutation Human genes 0.000 description 2
- 241000721662 Juniperus Species 0.000 description 2
- KVWWIYGFBYDJQC-GHMZBOCLSA-N Methyl dihydrojasmonate Chemical compound CCCCC[C@@H]1[C@@H](CC(=O)OC)CCC1=O KVWWIYGFBYDJQC-GHMZBOCLSA-N 0.000 description 2
- 241000219926 Myrtaceae Species 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- 235000006297 Origanum majorana Nutrition 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 241000199919 Phaeophyceae Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 241000234314 Zingiber Species 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 244000030166 artemisia Species 0.000 description 2
- 235000009052 artemisia Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 210000000467 autonomic pathway Anatomy 0.000 description 2
- 239000013040 bath agent Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 239000001851 juniperus communis l. berry oil Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940094506 lauryl betaine Drugs 0.000 description 2
- 229930007744 linalool Natural products 0.000 description 2
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 2
- 239000003915 liquefied petroleum gas Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- BOPPSUHPZARXTH-UHFFFAOYSA-N ocean propanal Chemical compound O=CC(C)CC1=CC=C2OCOC2=C1 BOPPSUHPZARXTH-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 210000005037 parasympathetic nerve Anatomy 0.000 description 2
- 239000001738 pogostemon cablin oil Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000010349 pulsation Effects 0.000 description 2
- 210000001747 pupil Anatomy 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- 235000019983 sodium metaphosphate Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- QPQANCNBWQXGTQ-UHFFFAOYSA-N trihydroxy(trimethylsilylperoxy)silane Chemical compound C[Si](C)(C)OO[Si](O)(O)O QPQANCNBWQXGTQ-UHFFFAOYSA-N 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 2
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- FMZUHGYZWYNSOA-VVBFYGJXSA-N (1r)-1-[(4r,4ar,8as)-2,6-diphenyl-4,4a,8,8a-tetrahydro-[1,3]dioxino[5,4-d][1,3]dioxin-4-yl]ethane-1,2-diol Chemical compound C([C@@H]1OC(O[C@@H]([C@@H]1O1)[C@H](O)CO)C=2C=CC=CC=2)OC1C1=CC=CC=C1 FMZUHGYZWYNSOA-VVBFYGJXSA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
- 229940098795 (3z)- 3-hexenyl acetate Drugs 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- UFLHIIWVXFIJGU-ARJAWSKDSA-N (Z)-hex-3-en-1-ol Chemical compound CC\C=C/CCO UFLHIIWVXFIJGU-ARJAWSKDSA-N 0.000 description 1
- 239000001875 1-phenylethyl acetate Substances 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- MFKRHJVUCZRDTF-UHFFFAOYSA-N 3-methoxy-3-methylbutan-1-ol Chemical compound COC(C)(C)CCO MFKRHJVUCZRDTF-UHFFFAOYSA-N 0.000 description 1
- HTLBMZKXJYNJSK-UHFFFAOYSA-N 3-naphthalen-2-yl-1,2-oxazol-5-amine Chemical compound O1C(N)=CC(C=2C=C3C=CC=CC3=CC=2)=N1 HTLBMZKXJYNJSK-UHFFFAOYSA-N 0.000 description 1
- CNJLMVZFWLNOEP-UHFFFAOYSA-N 4,7,7-trimethylbicyclo[4.1.0]heptan-5-one Chemical compound O=C1C(C)CCC2C(C)(C)C12 CNJLMVZFWLNOEP-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- ZVNPWFOVUDMGRP-UHFFFAOYSA-N 4-methylaminophenol sulfate Chemical compound OS(O)(=O)=O.CNC1=CC=C(O)C=C1.CNC1=CC=C(O)C=C1 ZVNPWFOVUDMGRP-UHFFFAOYSA-N 0.000 description 1
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 1
- 241001081440 Annonaceae Species 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 235000018062 Boswellia Nutrition 0.000 description 1
- 241000208229 Burseraceae Species 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 240000008384 Capsicum annuum var. annuum Species 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241000159174 Commiphora Species 0.000 description 1
- 101800004637 Communis Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000234646 Cyperaceae Species 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- HZPKNSYIDSNZKW-UHFFFAOYSA-N Ethyl 2-methylpentanoate Chemical compound CCCC(C)C(=O)OCC HZPKNSYIDSNZKW-UHFFFAOYSA-N 0.000 description 1
- 244000166124 Eucalyptus globulus Species 0.000 description 1
- 241000134874 Geraniales Species 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 241000208251 Gymnema Species 0.000 description 1
- 241000237369 Helix pomatia Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 240000001812 Hyssopus officinalis Species 0.000 description 1
- 235000010650 Hyssopus officinalis Nutrition 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 244000198896 Lagerstroemia speciosa Species 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 101150118484 Macf1 gene Proteins 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 102000015494 Mitochondrial Uncoupling Proteins Human genes 0.000 description 1
- 108010050258 Mitochondrial Uncoupling Proteins Proteins 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 240000007673 Origanum vulgare Species 0.000 description 1
- 235000004383 Origanum vulgare subsp. vulgare Nutrition 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241000745768 Pluchea carolinensis Species 0.000 description 1
- 240000002505 Pogostemon cablin Species 0.000 description 1
- 235000011751 Pogostemon cablin Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- 241000109329 Rosa xanthina Species 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241000220156 Saxifraga Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000007212 Verbena X moechina Moldenke Nutrition 0.000 description 1
- 240000001519 Verbena officinalis Species 0.000 description 1
- 235000001594 Verbena polystachya Kunth Nutrition 0.000 description 1
- 235000007200 Verbena x perriana Moldenke Nutrition 0.000 description 1
- 235000002270 Verbena x stuprosa Moldenke Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229920000800 acrylic rubber Polymers 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- GUUHFMWKWLOQMM-NTCAYCPXSA-N alpha-hexylcinnamaldehyde Chemical compound CCCCCC\C(C=O)=C/C1=CC=CC=C1 GUUHFMWKWLOQMM-NTCAYCPXSA-N 0.000 description 1
- GUUHFMWKWLOQMM-UHFFFAOYSA-N alpha-n-hexylcinnamic aldehyde Natural products CCCCCCC(C=O)=CC1=CC=CC=C1 GUUHFMWKWLOQMM-UHFFFAOYSA-N 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 238000000222 aromatherapy Methods 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 239000010620 bay oil Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229940007550 benzyl acetate Drugs 0.000 description 1
- VXQOANYOLHAZIN-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1.C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 VXQOANYOLHAZIN-UHFFFAOYSA-N 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 235000013614 black pepper Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000001772 cananga odorata hook. f. and thomas. oil Substances 0.000 description 1
- 238000009924 canning Methods 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- NPFVOOAXDOBMCE-PLNGDYQASA-N cis-3-Hexenyl acetate Natural products CC\C=C/CCOC(C)=O NPFVOOAXDOBMCE-PLNGDYQASA-N 0.000 description 1
- RRGOKSYVAZDNKR-ARJAWSKDSA-M cis-3-hexenylacetate Chemical compound CC\C=C/CCCC([O-])=O RRGOKSYVAZDNKR-ARJAWSKDSA-M 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000001941 cymbopogon citratus dc and cymbopogon flexuosus oil Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Polymers OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 229940087101 dibenzylidene sorbitol Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229930008394 dihydromyrcenol Natural products 0.000 description 1
- XSNQECSCDATQEL-UHFFFAOYSA-N dihydromyrcenol Chemical compound C=CC(C)CCCC(C)(C)O XSNQECSCDATQEL-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- PONXTPCRRASWKW-KBPBESRZSA-N diphenylethylenediamine Chemical compound C1([C@H](N)[C@@H](N)C=2C=CC=CC=2)=CC=CC=C1 PONXTPCRRASWKW-KBPBESRZSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 239000001902 eugenia caryophyllata l. bud oil Substances 0.000 description 1
- 239000001734 eugenia caryophyllata l. bud oleoresin Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 229940072117 fennel extract Drugs 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- ONKNPOPIGWHAQC-UHFFFAOYSA-N galaxolide Chemical compound C1OCC(C)C2=C1C=C1C(C)(C)C(C)C(C)(C)C1=C2 ONKNPOPIGWHAQC-UHFFFAOYSA-N 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- UFLHIIWVXFIJGU-UHFFFAOYSA-N hex-3-en-1-ol Natural products CCC=CCCO UFLHIIWVXFIJGU-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940014041 hyaluronate Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- SDQFDHOLCGWZPU-UHFFFAOYSA-N lilial Chemical compound O=CC(C)CC1=CC=C(C(C)(C)C)C=C1 SDQFDHOLCGWZPU-UHFFFAOYSA-N 0.000 description 1
- 125000000396 limonene group Chemical group 0.000 description 1
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000001780 majorana hortensis moench (origanum majorana l.) Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 125000005474 octanoate group Chemical group 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 230000001734 parasympathetic effect Effects 0.000 description 1
- 229940023750 peg-60 glyceryl isostearate Drugs 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229940057874 phenyl trimethicone Drugs 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 description 1
- 229940075559 piperine Drugs 0.000 description 1
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 description 1
- 235000019100 piperine Nutrition 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 235000015639 rosmarinus officinalis Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- KWVISVAMQJWJSZ-VKROHFNGSA-N solasodine Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CN1 KWVISVAMQJWJSZ-VKROHFNGSA-N 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008700 sympathetic activation Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- NPFVOOAXDOBMCE-UHFFFAOYSA-N trans-3-hexenyl acetate Natural products CCC=CCCOC(C)=O NPFVOOAXDOBMCE-UHFFFAOYSA-N 0.000 description 1
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 1
- UUJLHYCIMQOUKC-UHFFFAOYSA-N trimethyl-[oxo(trimethylsilylperoxy)silyl]peroxysilane Chemical compound C[Si](C)(C)OO[Si](=O)OO[Si](C)(C)C UUJLHYCIMQOUKC-UHFFFAOYSA-N 0.000 description 1
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- XWNXEWLCHSLQOI-UHFFFAOYSA-K trisodium;triacetate Chemical compound [Na+].[Na+].[Na+].CC([O-])=O.CC([O-])=O.CC([O-])=O XWNXEWLCHSLQOI-UHFFFAOYSA-K 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 239000001841 zingiber officinale Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fats And Perfumes (AREA)
- Seasonings (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION
【0001】[0001]
【発明の属する技術分野】本発明は交感神経を活性化す
る香料組成物に関する。より詳細には、少なくとも1種
以上の精油を含有する交感神経活性化香料に関する。The present invention relates to a perfume composition for activating a sympathetic nerve. More particularly, it relates to a sympathetic nerve-activating fragrance containing at least one or more essential oils.
【0002】[0002]
【従来の技術】自律神経系はその働きの違いから交感神
経系と副交感神経系に分類されており、各臓器や器官の
機能を相互に調節している。そのうち交感神経系の活性
化は心拍数増加、胃腸活動の抑制他、様々な作用を及ぼ
すことが知られており、ホルモン等の作用を受けると同
時に精神的な緊張状態によっても引き起こされる。一
方、香料が様々な精神作用を及ぼすことは伝承的にも良
く知られており、気持ちを落ち着ける香り、気分を高揚
させる香りなどが古くから知られている。2. Description of the Related Art The autonomic nervous system is classified into a sympathetic nervous system and a parasympathetic nervous system based on differences in their functions, and mutually regulates the function of each organ or organ. Among them, the activation of the sympathetic nervous system is known to exert various effects such as an increase in heart rate, suppression of gastrointestinal activity, and is also caused by a mental state while being affected by hormones and the like. On the other hand, it is traditionally well known that fragrances exert various mental effects, and scents that calm the mind and enhance scent have long been known.
【0003】更に近年では、その鎮静、覚醒作用が脳波
測定等によっても実証されつつある。このように香料が
精神作用をも含め全身系に様々な影響を及ぼすことは
「アロマテラピー」としても世界各地で臨床されてきた
が、しかしながら香料の自律神経系に対する作用として
は副交感神経系を活性化する香料が一部報告されている
にすぎず、これまでに交感神経系に作用する香料は全く
見出されていないのが現状である(特開平11-209294)。[0003] In recent years, their sedative and arousal effects have been demonstrated by brain wave measurements and the like. The fact that fragrances have various effects on the whole body system, including mental effects, has been clinically conducted around the world as "aromatherapy". However, the effect of fragrances on the autonomic nervous system is to activate the parasympathetic nervous system. At present, only a part of fragrances to be converted into fragrances has been reported, and no fragrances acting on the sympathetic nervous system have been found so far (JP-A-11-209294).
【0004】[0004]
【発明が解決しようとする課題】ストレスフルな現代社
会においては生体の恒常性維持に深い関わりを持つ自律
神経系調節剤として、副作用の少ない交感神経系活性化
剤の提供が望まれていた。In a stressful modern society, it has been desired to provide a sympathetic nervous system activator having few side effects as an autonomic nervous system regulator which is deeply involved in maintaining homeostasis of a living body.
【0005】[0005]
【課題を解決するための手段】本発明の発明者等は上記
課題を解決すべく鋭意検討した結果、ある種の香料の香
りが交感神経活性化作用を有する事を見出し、本発明を
完成した。すなわち、本発明は有効成分とする少なくと
も1種以上の香料よりなる交感神経活性化香料及びそれ
らを有効成分として含むことを特徴とする皮膚外用剤な
らびに雑貨類に関する。Means for Solving the Problems The inventors of the present invention have conducted intensive studies to solve the above-mentioned problems, and as a result, have found that a fragrance of a certain fragrance has a sympathetic nerve activating effect, and completed the present invention. . That is, the present invention relates to a sympathetic nerve activating fragrance comprising at least one kind of fragrance as an active ingredient, and an external preparation for skin and miscellaneous goods characterized by containing them as an active ingredient.
【0006】ここでいう香料はフェンネルオイル、グレ
ープフルーツオイル、ペッパーオイル、ヒソップオイ
ル、セージオイル、エストラゴンオイル、ユーカリオイ
ル、ローズマリーオイル、シンナモンオイル、クローブ
オイル、イランイランオイル、ジンジャーオイル、ゼラ
ニウムオイル又はオリバナムであることが好ましく、更
にこれら香料を組み合わせて用いる事もできる。また、
リモネン、ピネン、ミルセン又はベンジルベンゾエート
を含有することが好ましく、更に、これらの香料を組み
合わせて用いることも出来る。[0006] The fragrance here refers to fennel oil, grapefruit oil, pepper oil, hyssop oil, sage oil, estragon oil, eucalyptus oil, rosemary oil, cinnamon oil, clove oil, ylang ylang oil, ginger oil, geranium oil or It is preferably Oribanum, and these flavors may be used in combination. Also,
It preferably contains limonene, pinene, myrcene or benzyl benzoate, and these fragrances can be used in combination.
【0007】従って本発明は、フェンネルオイル、グレ
ープフルーツオイル、ペッパーオイル、ヒソップオイ
ル、セージオイル、エストラゴンオイル、ユーカリオイ
ル、ローズマリーオイル、シンナモンオイル、クローブ
オイル、イランイランオイル、ジンジャーオイル、ゼラ
ニウムオイル及びオリバナムより選ばれる1種又は2種以
上を含有することを特徴とする、あるいはリモネン、ピ
ネン、ミルセン及びベンジルベンゾエートより選ばれる
1種又は2種以上を含有することを特徴とする、交感神
経活性化香料組成物を提供する。本発明はさらに、上記
の香料組成物を有効成分として含むことを特徴とする皮
膚外用剤組成物又は雑貨類を提供する。Accordingly, the present invention provides fennel oil, grapefruit oil, pepper oil, hyssop oil, sage oil, estragon oil, eucalyptus oil, rosemary oil, cinnamon oil, clove oil, ylang ylang oil, ginger oil, geranium oil and Characterized by containing one or more selected from Olibanum, or containing one or more selected from limonene, pinene, myrcene and benzyl benzoate, activating sympathetic nerves A perfume composition is provided. The present invention further provides a skin external preparation composition or miscellaneous goods comprising the above-mentioned perfume composition as an active ingredient.
【0008】本発明はさらに、フェンネルオイル、グレ
ープフルーツオイル、ペッパーオイル、ヒソップオイ
ル、セージオイル、エストラゴンオイル、ユーカリオイ
ル、ローズマリーオイル、シンナモンオイル、クローブ
オイル、イランイランオイル、ジンジャーオイル、ゼラ
ニウムオイル及びオリバナムより選ばれる1種又は2種以
上を含有することを特徴とする、あるいはリモネン、ピ
ネン、ミルセン及びベンジルベンゾエートより選ばれる
1種又は2種以上を含有することを特徴とする、痩身用
香料組成物を提供する。The present invention further provides fennel oil, grapefruit oil, pepper oil, hyssop oil, sage oil, estragon oil, eucalyptus oil, rosemary oil, cinnamon oil, clove oil, ylang ylang oil, ginger oil, geranium oil and A slimming fragrance composition comprising one or more selected from Olibanum, or one or more selected from limonene, pinene, myrcene and benzyl benzoate. Offer things.
【0009】本発明はさらに、フェンネルオイル、グレ
ープフルーツオイル、ペッパーオイル、ヒソップオイ
ル、セージオイル、エストラゴンオイル、ユーカリオイ
ル、ローズマリーオイル、シンナモンオイル、クローブ
オイル、イランイランオイル、ジンジャーオイル、ゼラ
ニウムオイル及びオリバナムより選ばれる1種又は2種以
上を含有することを特徴とする、あるいはリモネン、ピ
ネン、ミルセン及びベンジルベンゾエートより選ばれる
1種又は2種以上を含有することを特徴とする、記憶力
向上香料組成物を提供する。The present invention further provides fennel oil, grapefruit oil, pepper oil, hyssop oil, sage oil, estragon oil, eucalyptus oil, rosemary oil, cinnamon oil, clove oil, ylang ylang oil, ginger oil, geranium oil and A memory-enhancing fragrance composition characterized by containing one or more kinds selected from Olibanum, or containing one or more kinds selected from limonene, pinene, myrcene and benzyl benzoate. Offer things.
【0010】本発明はさらに、フェンネルオイル、グレ
ープフルーツオイル、ペッパーオイル、ヒソップオイ
ル、セージオイル、エストラゴンオイル、ユーカリオイ
ル、ローズマリーオイル、シンナモンオイル、クローブ
オイル、イランイランオイル、ジンジャーオイル、ゼラ
ニウムオイル及びオリバナムより選ばれる1種又は2種以
上をかがせることを特徴とする、あるいはリモネン、ピ
ネン、ミルセン及びベンジルベンゾエートより選ばれる
1種又は2種以上を含有することを特徴とする、痩身方
法を提供する。本発明は更に、前記の交感神経活性化香
料組成物を有効成分として含有することを特徴とする痩
身用組成物を提供する。この組成物は、カフェインを更
に含有することが好ましい。The present invention further relates to fennel oil, grapefruit oil, pepper oil, hyssop oil, sage oil, estragon oil, eucalyptus oil, rosemary oil, cinnamon oil, clove oil, ylang ylang oil, ginger oil, geranium oil and A method of slimming, characterized in that one or more kinds selected from Olibanum are bent, or one or more kinds selected from limonene, pinene, myrcene and benzyl benzoate are contained. provide. The present invention further provides a slimming composition comprising the above-mentioned sympathetic nerve activating fragrance composition as an active ingredient. Preferably, the composition further contains caffeine.
【0011】[0011]
【発明の実施の形態】以下に本発明を詳細に説明する。精油の製法 ペッパーオイル ペッパーオイルはコショウ科に属するPiper属植物の未
熟の漿果を乾燥し黒変した外皮をつけたまま水蒸気蒸留
することにより得られる。その香気は刺激的な清涼感が
あり食品用香辛料として世界中で汎用されている(日本
香料協会編、「香りの百科」より)。DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below in detail. Method for producing essential oil Pepper oil Pepper oil is obtained by steam-distilling an immature berry of a Piper genus plant belonging to the family Pepper, with a dried and blackened outer skin. The fragrance has an exciting refreshing sensation and is widely used as a spice for food all over the world (from Japan Fragrance Association, edited by "Aroma Encyclopedia").
【0012】クローブオイル クローブはフトモモ科の常緑樹で漢方では「丁子」と称
される。開花前の花蕾を摘み取りよく乾燥して水蒸気蒸
留したものをclove bud oil、葉あるいは小枝から水蒸
気蒸留により得られるものをclove leaf oilと称し、い
ずれも香粧品用・食品用香料として用いられている。Eu
genolを主要成分とするウッデイー・スパイシーな香気
をもつ(日本香料協会編、「香りの百科」より)。 Clove oil clove is an evergreen tree of the family Myrtaceae and is called "cushi" in Chinese medicine. The flower buds before flowering are picked, dried well and steam-distilled are called clove bud oil, and those obtained by steam distillation from leaves or twigs are called clove leaf oil, all of which are used as fragrances for cosmetics and foods. . EU
It has a woody, spicy scent with genol as the main ingredient (edited by the Japan Fragrance Association, "Encyclopedia of Scents").
【0013】エストラゴンオイル エストラゴンはキク科ヨモギ属に属するArtemisia drue
unculusでフランスのエスカルゴ料理にも使われる。ヨ
ーロッパ・北アメリカなどで栽培された開花期の地上部
全草を刈り取り乾燥させ水蒸気蒸留に供しオイルを得
る。香気の主成分はEstragoleで甘いアニス調香気を有
する(日本香料協会編、「香りの百科」より)。 Estragon oil Estragon is an Artemisia drue belonging to the genus Artemisia of the family Asteraceae.
It is also used in French escargot cuisine in unculus. All the above-ground parts of the flowering season grown in Europe and North America are cut, dried and subjected to steam distillation to obtain oil. The main component of the fragrance is Estragole, which has a sweet anise-like fragrance (from "Fragrance Encyclopedia", edited by Japan Fragrance Association).
【0014】ヒソップオイル ヒソップはシソ科ヤナギハッカ属の植物で古来より医薬
品としても重用されてきた。葉と花穂の部分を刈り取
り、水蒸気蒸留することにより清涼感のあるオイルを得
る(日本香料協会編、「香りの百科」より)。 Hyssop Oil Hyssop is a plant belonging to the genus Perilla in the Labiatae family, and has been used as a pharmaceutical since ancient times. The leaves and spikes are cut off and steam distilled to obtain a refreshing oil (from "Perfume Encyclopedia", edited by Japan Fragrance Association).
【0015】セージオイル セージはシソ科アキギリ属に分類される草本で世界各地
に多種分布する。オイルは乾燥葉を水蒸気蒸留すること
により得られ、新鮮なハーブ調香気を有する。食品用香
辛料としても世界各地で汎用されている(日本香料協会
編、「香りの百科」より)。[0015] Sage oil sage is a herb classified in the Labiatae family of the genus Lamiaceae, and is widely distributed throughout the world. The oil is obtained by steam distillation of the dried leaves and has a fresh herbal aroma. It is also widely used as a spice for food in various parts of the world (from Japan Fragrance Association, “Encyclopedia of Fragrances”).
【0016】ユーカリオイル ユーカリはフトモモ科に属する常緑樹で木材としても重
要である。熱帯・亜熱帯に各種が分布し、葉及び小枝を
乾燥させたものを水蒸気蒸留に供しオイルを得る(日本
香料協会編、「香りの百科」より)。 Eucalyptus oil Eucalyptus is an evergreen tree belonging to the family Myrtaceae and is also important as wood. Various types are distributed in the tropics and subtropics, and dried leaves and twigs are subjected to steam distillation to obtain an oil (from "Perfume Encyclopedia", edited by Japan Fragrance Association).
【0017】グレープフルーツオイル グレープフルーツは、学名Citrus paradis Macf.とい
い、西インド諸島原産のミカン科の常緑樹である。さわ
やかな甘みと苦みをもつ果実で、香料は果汁製造と同時
に得る。香気主成分はリモネンで特有のシトラス香を有
する(日本香料協会編、「香りの百科」より)。 Grapefruit Oil Grapefruit is a so-called Citrus paradis Macf., An evergreen tree of the Rutaceae family native to the West Indies. It is a fruit with a refreshing sweetness and bitterness. The main fragrance is limonene, which has a unique citrus scent (from "The Encyclopedia of Fragrances", edited by Japan Fragrance Association).
【0018】フェンネルオイル フェンネルはセリ科に属し、茴香または小茴香と呼ばれ
ヨ−ロッパ原産の多年草で有史以前より薬草として用い
られていた。日本にも平安時代に渡来し、現在では世界
中で広く栽培されている。果実は芳香と甘みを有し、水
蒸気蒸留により精油を得る。精油の主要成分はアネトー
ルで特有の甘い芳香を有している(日本香料協会編、
「香りの百科」より)。[0018] fennel oil fennel belongs to the Umbelliferae, Yo is referred to as fennel or small fennel - has been used from prehistoric times as a medicinal herb in Europe native perennial. It was introduced to Japan during the Heian period and is now widely cultivated worldwide. The fruit has aroma and sweetness, and the essential oil is obtained by steam distillation. The main component of essential oil has a sweet aroma unique to anethole (edited by Japan Fragrance Association,
"From the Encyclopedia of Fragrance").
【0019】ローズマリーオイル ローズマリーオイルは地中海沿岸の諸国に広く分布する
シソ科の常緑低木(学名 Rosmarinus officinalis)
の、葉や花を水蒸気蒸留することにより得られる、さわ
やかな甘い香りの香気成分である。医薬品の有効成分と
してまた、香味料や香粧品用香料として広く用いられて
いる(「香りの百科」より)。 Rosemary oil Rosemary oil is an evergreen shrub of the Labiatae (scientific name: Rosmarinus officinalis) which is widely distributed in Mediterranean countries.
It is a refreshing sweet scent obtained by steam distillation of leaves and flowers. It is widely used as an active ingredient of pharmaceuticals and as a flavoring agent or a flavoring agent for cosmetics (from "Aroma Encyclopedia").
【0020】イランイランオイル イランイランはバンレイシ科(Anonaceae)に属する植
物(Canning odorata)の花をそのままの状態で水蒸気
蒸留、もしくは生花を石油エーテルなどで溶媒抽出する
ことにより得られる。古くから知られたもっとも重要な
香料植物のひとつで、温和なジャスミンを想起させるフ
ローラルな香気を有している。花香調調合香料の調和剤
として、また食品用香料にも用いられる(「香りの百
科」より)。 Ylang-ylang oil Ylang-ylang is obtained by steam distillation of a plant belonging to the family Annonaceae (Canning odorata) as it is, or by solvent extraction of a fresh flower with petroleum ether or the like. One of the most important fragrance plants known since ancient times, it has a floral aroma reminiscent of mild jasmine. It is also used as a harmony for fragrances and fragrances for foodstuffs (from "Scent Encyclopedia").
【0021】シンナモンオイル シンナモンは東南アジアを原産とするクスノキ科の常緑
喬木で、その香気は甘美な芳香とやや収斂性のある刺激
味が特徴的である。シンナモンオイルは、皮を砕き水蒸
気蒸留することによって得られるが、別に葉や小枝を水
蒸気蒸留することによってもオイルが得られる。その形
態別にそれぞれの特徴を活かし、食品をはじめ、化粧
品、医薬品など広範囲にわたって利用されている(「香
りの百科」より)。 Cinnamon Oil Cinnamon is an evergreen Takagi tree of the camphoraceae family native to Southeast Asia, and its aroma is characterized by a sweet aroma and a slightly astringent stimulating taste. Cinnamon oil can be obtained by crushing the skin and subjecting it to steam distillation, but can also obtain oil by separately steam-distilling leaves and twigs. Utilizing the characteristics of each form, it is widely used in foods, cosmetics, and pharmaceuticals (from "Encyclopedia of Aroma").
【0022】ジンジャーオイル ジンジャーオイルは、そのまま調理にも用いられるショ
ウガ科の多年生草本ジンジャー(Zingiber officinale
Roscoe)の根茎を乾燥させ、水蒸気蒸留することにより
得られる。産地によってその風味は微妙に異なり、その
特性に応じて飲料、蓄肉製品、調味料などに利用されて
いる(「香りの百科」より)。 Ginger oil Ginger oil is a perennial herb ginger (Zingiber officinale) of the ginger family which is also used for cooking as it is.
Roscoe) is obtained by drying the rhizome and subjecting it to steam distillation. The flavor varies slightly depending on the place of origin, and depending on its characteristics, it is used in beverages, meat storage products, seasonings, etc. (from "Aroma Encyclopedia").
【0023】ゼラニウムオイル ゼラニウムはフウロウソウ科のテンジクアオイ(Pelarg
onium)属の植物であり、ゼラニウムオイルは、その枝
葉を花が開く前に集めて、約1日放置後水蒸気蒸留する
ことにより得られ、香料素材として10本の指に入るほど
重要なものである。その力強いローズ様の匂いのため、
すべての調合香料に使用でき、アルカリ媒体中でも安定
で匂いが変化しないため、高級石けん、洗剤への賦香に
しばしば使用される(「香りの百科」より)。 Geranium Oil Geranium is a member of the family Anthracidae (Pelarg).
geranium oil is obtained by collecting its branches and leaves before the flower opens, leaving it for about one day, and then steam distilling it. is there. Because of the strong rose-like smell,
It can be used in all compounded fragrances, is stable in alkaline medium and does not change its odor, and is often used for perfuming high-grade soaps and detergents (from "Encyclopedia of Scents").
【0024】オリバナム 東北アメリカ、南アラビア、またインドのやせ地に自生
する、フロウソウ目カンラン科Geraniales Burseraceae
の植物Boswellia carterii Birdwなどの潅木あるいは小
喬木の樹皮より滲出する樹脂。別名フランクインセン
ス、あるいは乳香。樹脂そのものの香気は弱いがこれを
火に焚くときわめて強い独特の香気を発し、古くから宗
教儀式の際に用いられた。この樹脂から有機溶媒抽出し
て得られるレジノイドなどがオリエンタル調の調合香料
に用いられる(「香りの百科」より)。[0024] olibanum northeast America, South Arabia, also native to the poor soils of India, Furousou eyes Burseraceae Geraniales Burseraceae
Resin exuding from the bark of shrubs and small trees such as Boswellia carterii Birdw. Also known as Frankincense or frankincense. The fragrance of the resin itself is weak, but when it is lit on fire, it emits a very strong and unique fragrance, which has long been used during religious ceremonies. Resinoids and the like obtained by extracting an organic solvent from this resin are used for oriental-like compounded fragrances (from "Scent Encyclopedia").
【0025】その他の原料の説明 リモネン 代表的単環式テルペン。無色液体。右旋性d(+)-と左旋
性l(-)-の光学異性体である。α体はオレンジ、レモン
などの果皮を水蒸気蒸留して得られる精油を分留し、l
体はハッカ油から得られる(合成香料 化学と商品知識
印藤元一著 化学工業日報より)。ピネン テルペン系炭化水素の代表的存在で、多くの精油に含有
されており、特に松柏科植物に最も多く存在する。 Description of Other Raw Materials Representative limonene monocyclic terpene. Colorless liquid. It is an optical isomer of dextrorotatory d (+)-and levorotatory l (-)-. α-isomer fractionates essential oils obtained by steam distillation of pericarp such as oranges and lemons.
The body is obtained from peppermint oil (from synthetic perfume chemistry and product knowledge by Motoichi Indo, Chemical Daily). It is a representative of pinenterpene-based hydrocarbons and is contained in many essential oils, especially in pinnaceae.
【0026】ミルセン β-ピネンの熱分解によって大量に製造される。天然に
は、ベイ油、ベルベナ油、ホップ油、ガルバナム油、レ
モングラス油などに存在する。甘いバルサムないしレジ
ン様香気の無色〜淡褐色液体である。ベンジルベンゾエート 安息香酸ベンジル。トルーバルサム、ペルーバルサム、
ジャスミン油、シンナモン油、カナンガ油などに存在す
る。わずかにフローラルで甘いバルサム様香気の無色液
体。重い感じのフローラル系やオリエンタル調の調合香
料に保留剤、変調剤として、またバルサム、レジノイド
類などの溶剤として広く用いられる。It is produced in large quantities by the thermal decomposition of myrcene β-pinene. Naturally, it is present in bay oil, verbena oil, hop oil, galvanum oil, lemongrass oil and the like. It is a colorless to light brown liquid with a sweet balsam or resinous odor. Benzyl benzoate benzyl benzoate . True Balsam, Peruvian Balsam,
It is present in jasmine oil, cinnamon oil, cananga oil and the like. Colorless liquid with slightly floral and sweet balsam-like aroma. It is widely used as a retention agent and modulator in heavy floral or oriental compounded fragrances and as a solvent for balsams and resinoids.
【0027】本発明におけるこれら精油の配合量は選択
する精油の種類や他の配合成分との関係等により適宜選
択されるものであり、特に限定されるものではない。通
常、香料組成物中(香料処方中)0.001〜100重量%、好
ましくは10〜100重量%用いられる。本発明組成物は例
えば化粧料、医薬品、医薬部外品等の皮膚外用剤用香料
組成物、インセンス、空間散布剤等の雑貨類用香料組成
物、さらには飲料、食品用香料組成物としての用途を取
りうるが、これら用途に限定されるものではない。ま
た、上記交感神経活性化香料以外に、本組成物が取りう
る具体的な態様に応じて、一般的な香料成分を本発明の
効果を損なわない限り配合することが出来る。更に、交
感神経活性化は痩身および記憶力向上を引き起こすこと
が知れており、上記精油組成をこのような用途に用いる
ことも出来る。The amount of these essential oils in the present invention is appropriately selected depending on the type of essential oil to be selected, the relationship with other components, and the like, and is not particularly limited. Usually, it is used in an amount of 0.001 to 100% by weight, preferably 10 to 100% by weight in the flavor composition (in the flavor formulation). The composition of the present invention is, for example, a cosmetic composition, a pharmaceutical composition, a fragrance composition for external preparations on the skin such as quasi-drugs, an incense composition, a fragrance composition for miscellaneous goods such as a space spray, and a beverage, a fragrance composition for food. However, the present invention is not limited to these uses. In addition to the above-mentioned sympathetic nerve-activating fragrance, a general fragrance component can be blended according to a specific mode that the present composition can take as long as the effects of the present invention are not impaired. In addition, sympathetic activation is known to cause slimming and improved memory, and the above essential oil compositions can be used for such applications.
【0028】本発明の香料組成物はそれ自体で単独で使
用することもでき、さらに他の交感神経活性化剤、例え
ばカプサイシン、ジンゲロン、ピペリン等、及び/又は
他の抗肥満・痩身成分、例えばカフェイン等のキサンチ
ン誘導体、中国茶、緑茶抽出物、ウイキョウ、シャクヤ
ク、ショウキュウ、ラベンダー、トウガラシなどの生
薬、タマリンド、ギムネマシルベスター、イノシット、
デキストラン硫酸などと併用することも出来る。The fragrance composition of the present invention can be used alone by itself, and may further contain other sympathetic activators such as capsaicin, zingerone, piperine and the like, and / or other anti-obesity / slimming ingredients such as Xanthin derivatives such as caffeine, Chinese tea, green tea extract, fennel, peonies, ginger, lavender, red pepper and other crude drugs, tamarind, gymnema sylvester, inosit,
It can be used in combination with dextran sulfate or the like.
【0029】特に、本発明を痩身に用いる場合、カフェ
インと併用する事により更に痩身効果を高めることが出
来る。すなわち交感神経の活性化により体内に分泌され
るノルアドレナリンとカフェインとの相乗効果により、
脂肪の燃焼が起こり、より高い痩身効果が得られる。こ
の相乗効果は、例えば、実施例2及び実施例3から明ら
かである。実施例2においては、本発明の香料組成物に
より血中カテコールアミン類(アドレナリン及びノルア
ドレナリン)が増加する事が明らかである。また、実施
例3において、ノルアドレナリンとカフェインとによる
脱共役蛋白質−3の発現増加が、相乗的に生ずることが
あきらかである。In particular, when the present invention is used for slimming, the slimming effect can be further enhanced by using it in combination with caffeine. In other words, due to the synergistic effect of noradrenaline and caffeine secreted into the body by activating the sympathetic nerve,
Fat burning occurs, resulting in a higher slimming effect. This synergistic effect is evident, for example, from Example 2 and Example 3. In Example 2, it is apparent that the fragrance composition of the present invention increases blood catecholamines (adrenaline and noradrenaline). Further, in Example 3, it is apparent that the increase in the expression of uncoupling protein-3 by noradrenaline and caffeine occurs synergistically.
【0030】特願2001-258346号明細書に記載されてい
る通り、脱共役蛋白質−3によるエネルギー消費(脂肪
の消費)により、体重の減少が起こる。従って、本発明
の香料組成物にカフェインを加える事により、痩身効果
が相乗的に生ずることが、合理的に推定される。なお、
本発明の香料組成物とカフェインとの組成物はこれらの
混合物であればよい。このような混合物を肌に適用した
場合、香気成分は蒸発して鼻から嗅がれ、カフェインは
経皮的に吸収される。As described in the specification of Japanese Patent Application No. 2001-258346, weight loss occurs by energy consumption (fat consumption) by uncoupling protein-3. Therefore, it is reasonably estimated that the addition of caffeine to the fragrance composition of the present invention produces a synergistic slimming effect. In addition,
The composition of the perfume composition of the present invention and caffeine may be a mixture of these. When such a mixture is applied to the skin, the aroma components evaporate and are smelled from the nose, and caffeine is absorbed transdermally.
【0031】カフェインの配合量は、薬剤としては0.00
1〜5重量%配合される。香料賦香率の目安としては、
次の通りである。 製品の種類 香料賦香率 化粧水 0.001〜0.05 乳液 0.03〜0.2 クリーム 0.05〜0.2 ジェル 0.005〜0.2 エアロゾール 0.001〜30 入浴剤 0.2〜3 フレグランス/ルームフラグランス 1〜100 インセンス 1〜30 フォームパック 0.03〜0.2The compounding amount of caffeine is 0.00
1 to 5% by weight is blended. As a guide of the fragrance perfume rate,
It is as follows. Product type Perfume flavoring rate Lotion 0.001 to 0.05 Emulsion 0.03 to 0.2 Cream 0.05 to 0.2 Gel 0.005 to 0.2 Aerosol 0.001 to 30 Bath agent 0.2 to 3 Fragrance / room fragrance 1 to 100 Incense 1 to 30 Foam pack 0.03 ~ 0.2
【0032】自律神経活性の評価 自律神経は交感神経と副交感神経に大別されており、内
臓器官や腺の調節をになっている。その際、腺や筋に直
接作用を及ぼすのは神経末端から放出されるアドレナリ
ン、アセチルコリンで、心臓、血管、瞳孔、胃腸活動、
汗腺等の働きをほぼ拮抗的に調節している。従って、自
律神経活動の測定方法としては、アドレナリンやアセチ
ルコリン量を直接的に測定する方法や、心拍、血流・血
圧、発汗、瞳孔反応等を測定する方法が各種報告されて
いる(「生理心理学」福村出版)。香料の自律神経系に
対する作用を測定するにあたっては、適切な方法であれ
ば、特に測定方法は限定されない。 Evaluation of Autonomic Nerve Activity Autonomic nerves are roughly classified into sympathetic nerves and parasympathetic nerves, and regulate internal organs and glands. At that time, it is adrenaline and acetylcholine released from nerve endings that directly act on glands and muscles, and the heart, blood vessels, pupils, gastrointestinal activity,
It regulates the activities of sweat glands and the like almost antagonistically. Therefore, various methods for measuring autonomic nervous activity include methods for directly measuring adrenaline and acetylcholine levels, and methods for measuring heart rate, blood flow / blood pressure, sweating, pupil reaction, etc. Gaku ”Fukumura Publishing). In measuring the effect of the fragrance on the autonomic nervous system, the measuring method is not particularly limited as long as it is an appropriate method.
【0033】[0033]
【実施例】以下、実施例により本発明を詳細に説明する
が、本発明はこれらに限定されるものではない。実施例1.交感神経活性の測定 心拍の間隔(拍動間隔)あるいは血圧の変動(血圧ゆら
ぎ)は安静時にも複雑に変動しており交感神経・副交感
神経を代表とする複数の系で支配されている。従って、
拍動間隔あるいは血圧ゆらぎを周波数解析することによ
り各系の活性度を算出できることが知られている。心拍
変動の高周波成分は副交感神経活性、低周波成分は交感
神経系と副交感神経系の混合した活性を示し、一方、血
圧変動の低周波成分は交感神経活性を示している(大日
本製薬資料)。The present invention will be described below in detail with reference to examples, but the present invention is not limited to these examples. Embodiment 1 FIG. Measurement of Sympathetic Nerve Activity The heartbeat interval (pulsation interval) or blood pressure fluctuation (blood pressure fluctuation) fluctuates in a complicated manner even at rest, and is governed by a plurality of systems represented by the sympathetic nerve and parasympathetic nerve. Therefore,
It is known that the activity of each system can be calculated by frequency analysis of the pulsation interval or blood pressure fluctuation. The high frequency component of heart rate variability indicates parasympathetic nervous activity, and the low frequency component indicates mixed activity of the sympathetic nervous system and parasympathetic nervous system, while the low frequency component of blood pressure variability indicates sympathetic nervous activity (Dainippon Pharmaceutical) .
【0034】そこで、交感神経活性は自律神経系活性解
析システム(フラクレット、大日本製薬株式会社製)を
用い収縮期血圧変動を解析することにより測定した。被
験者は室温24度の恒温室にて5分間安静後上腕部血圧
値を測定し手首部分の血圧値を補正後、手首部分より連
続的に血圧測定を行った。測定開始時に鼻下にコットン
を装着し3分間香りなしの状態で血圧測定した後、香り
を鼻下コットンに染み込ませ3分間血圧測定した。測定
値の収縮期血圧変動の低周波成分を求め、交感神経活動
を算出し香り無し(前半3分間)に対する香りあり(後
半3分間)の時の交感神経活動相対値を求めて香りの交
感神経に対する影響を測定した。Therefore, the sympathetic nerve activity was measured by analyzing systolic blood pressure fluctuation using an autonomic nervous system activity analysis system (Fraclet, manufactured by Dainippon Pharma Co., Ltd.). After resting in a constant temperature room at room temperature of 24 ° C. for 5 minutes, the upper arm blood pressure value was measured, the blood pressure value of the wrist was corrected, and then the blood pressure was continuously measured from the wrist. At the start of the measurement, cotton was placed under the nose and blood pressure was measured for 3 minutes without scent. Then, the scent was soaked in the cotton under the nose and the blood pressure was measured for 3 minutes. Obtain the low-frequency component of the measured systolic blood pressure fluctuation, calculate the sympathetic nerve activity, and calculate the relative value of the sympathetic nerve activity when there is a scent (the latter three minutes) with no scent (the first three minutes), and the sympathetic nerve of the scent Was measured.
【0035】フェンネルオイル、グレープフルーツオイ
ル、ペッパーオイル、ヒソップオイル、セージオイル、
エストラゴンオイル、ユーカリオイル、ローズマリーオ
イル、シンナモンオイル、クローブオイル、イランイラ
ンオイル、ジンジャーオイル、ゼラニウムオイル、オリ
バナムを提示した場合、香り無しに比較して1.2〜
3.0倍の交感神経の活性化を認めた(図1)。香りの
感じられないTEC(トリエチルシトレート)を提示し
た場合には交感神経活動相対値は変動しなかった。更
に、交感神経を活性化させた香料のGC/MS分析を行なっ
た結果、これらの効果香料に共通する成分として、リモ
ネン、ピネン、ミルセン及びベンジルベンゾエートを見
出した。これらの香料成分についても、同様の方法で香
りを嗅いだ時の交感神経活性を測定した結果、交感神経
活性の上昇効果を見出した(図2)。Fennel oil, grapefruit oil, pepper oil, hyssop oil, sage oil,
When presenting estragon oil, eucalyptus oil, rosemary oil, cinnamon oil, clove oil, ylang-ylang oil, ginger oil, geranium oil, oribanum, it is 1.2 ~
A 3.0-fold activation of the sympathetic nerve was observed (FIG. 1). When TEC (triethyl citrate) with no smell was presented, the relative value of sympathetic nerve activity did not change. Furthermore, as a result of conducting GC / MS analysis of the fragrance which activated the sympathetic nerve, limonene, pinene, myrcene and benzyl benzoate were found as components common to these fragrances. As for these fragrance components, the sympathetic nerve activity when smelling the scent was measured in the same manner, and as a result, an effect of increasing the sympathetic nerve activity was found (FIG. 2).
【0036】比較例1 またこれら活性化効果をもつ精油に対し、ローズオイ
ル、ミルオイル、マージョラムオイル、ジュニパーベリ
ーオイル、パチョリオイルなどは交感神経活性を鎮静化
する効果があった(図1)。ローズオイル バラの魅力的ある快適な香りは、今日世界中によく知ら
れ認められている。古来そのために花の女王とみられて
きた。ローズオイルはアブソリュートに比べ、強さ、匂
いの持ち上げ華やかさをその特徴とし、フローラルなベ
ース、シプレー、オリエンタルなベースなどによく用い
られている(「香りの百科」より)。 Comparative Example 1 Against the essential oils having an activating effect, rose oil, mill oil, marjoram oil, juniper berry oil, patchouli oil and the like had an effect of calming the sympathetic nerve activity (FIG. 1). The attractive and pleasant aroma of rose oil roses is now well known and recognized around the world. Since ancient times it has been regarded as the Queen of Flowers. Rose oil is characterized by its strength, fragrance lift and gorgeousness compared to absolute, and is often used for floral bases, shipplies, and oriental bases (from "Encyclopedia of Scents").
【0037】ミルオイル 主としてフウロソウ目カンラン科ミラルノキ属Geranial
es Burseraceae Commiphoraの樹皮から滲出する樹脂。
ミラルノキ属はアフリカ、アラビアに60種以上存在し、
樹皮の傷から染み出た樹液が空気に触れて、深みのある
甘くスパイシーなバルサム調の塊状樹脂となる。調合香
料としては、オリエンタル調のものに、よく使われ、フ
レーバー用としてはその苦み・辛みを生かした口中剤、
歯磨き等として用いられている(「香りの百科」よ
り)。 Mill oil Mainly Geranial
es Resin exuding from the bark of Burseraceae Commiphora.
There are more than 60 species of genus
The sap that oozes from the bark wounds comes into contact with the air and forms a deep, sweet, spicy, balsam-like mass. As a compounding flavor, it is often used for oriental ones, and for flavors, a mouthwash utilizing its bitterness and spiciness,
It is used as a toothpaste (from "Scent Encyclopedia").
【0038】マージョラムオイル マージョラムは、地中海東部沿岸を原産とするシソ科の
植物で、代表的なものとしては、スイートマージョラム
(Origanum majorana)、スパニッシュワイルドマージ
ョラムなどがある。マージョラムは温暖な地域で広く栽
培されており、スパイスとしての用途が主である。その
ほか、香水、芳香薬、コロン、オリエンタルベースとし
て用いられる(「香りの百科」より)。 Marjoram Oil Marjoram is a plant of the Labiatae native to the eastern coast of the Mediterranean Sea, and typical examples include sweet marjoram (Origanum majorana) and Spanish wild marjoram. Marjoram is widely cultivated in temperate regions and is mainly used as a spice. In addition, it is used as a perfume, fragrance, colon, oriental base (from "Encyclopedia of Aroma")
【0039】ジュニパーベリーオイル ジュニパーはヒノキ科ネズミサシ属の一種(Juniperius
communis L.)で、樹高3mになる常緑樹である。ヨー
ロッパ、アジア、北アメリカなどに広く野生する。ジュ
ニパーの完熟した青黒い2年ものの実からオイルを得
る。そのオイルはバルサミック、ウッディ、パインニー
ドル様の香気があり、洋酒の香りづけ、ドリンク、口内
清涼剤などに用いられる(「香りの百科」より)。 Juniper berry oil Juniper is a member of the genus Cyperaceae (Juniperius).
communis L.), an evergreen tree with a height of 3 m. It is widely wild in Europe, Asia and North America. Obtain oil from Juniper's ripe blue-black two-year-old fruit. The oil has a balsamic, woody, pine needle-like aroma and is used in the aroma of Western liquors, drinks, oral fresheners, etc. (from "Aroma Encyclopedia").
【0040】パチョリオイル パチョリは南方アジア原産のシソ科の多年生草本であ
り、生葉のときにはほとんど匂いがないが、乾燥すると
匂いがたってくる。主に直火方式の蒸留によりオイルを
得、その重く、東洋的なイメージの強い香りはフローラ
ル系、シトラス系などの香りに広く用いられている。 Patchouli oil Patchouli is a perennial herb belonging to the Labiatae native to southern Asia and has almost no smell when fresh leaves, but smells when dried. Oil is obtained mainly by direct-fired distillation, and its heavy, oriental image scent is widely used for floral and citrus scents.
【0041】比較例2 精油の香りと熱水抽出物の香りについて、交感神経活動
への影響を比較した。精油としてはペッパーオイル。熱
水抽出物としては常法に従って調製したブラックペッパ
ー、グリーンペッパー熱水抽出物を用いた。その結果、
精油の香りに高い効果があったのに比し、熱水抽出物の
香りには効果が認められず、精油中に含まれる香り成分
が交感神経の活性化に大きく寄与していることが判明し
た(図3)。 Comparative Example 2 The effects of the essential oil scent and the hot water extract scent on the sympathetic nerve activity were compared. The essential oil is pepper oil. As the hot water extract, black pepper and green pepper hot water extracts prepared according to a conventional method were used. as a result,
Compared to the high effect on the scent of essential oils, no effect was found on the scent of hot water extract, indicating that the scent components contained in the essential oils greatly contributed to the activation of sympathetic nerves (Fig. 3).
【0042】実施例2.交感神経活性化香料の香りによ
る血中カテコールアミン類の増加 交感神経を活性化させる香料中から、例としてペッパー
オイルとグレープフルーツオイルを取り上げ、これらの
香料の香りを嗅ぐことによる血中カテコールアミン類の
濃度の変化を調べた。12名の被験者に、それぞれペッパ
ーオイル又はグレープフルーツオイルの香りを嗅がせ、
香りを嗅ぐ前と、7分間香りを嗅いだ後の血中のカテコ
ールアミン類の濃度を比較した。被験者を椅子に着席さ
せ、30分間安静状態を保った後、5mlの血液を採取し、
香りの提示前のサンプルとした。 Embodiment 2 FIG . Due to the fragrance of the sympathetic activating fragrance
Increase in blood catecholamines Among the fragrances that activate the sympathetic nerves, pepper oil and grapefruit oil were taken as examples, and changes in blood catecholamines concentration by smelling the fragrance of these fragrances were examined. Twelve subjects smell the aroma of pepper oil or grapefruit oil, respectively.
The concentrations of catecholamines in blood were compared before smelling and after smelling for 7 minutes. After the subject was seated in a chair and kept at rest for 30 minutes, 5 ml of blood was collected,
The sample before the presentation of the scent was used.
【0043】安静状態を保ったままの被験者の鼻下に、
精油を染み込ませた脱脂綿を添付して香りを嗅がせ、7
分間後に再び5mlの血液を採取して香りを提示したサン
プルとした。血液の採取にはADTA.2NA入り採取管を用い
た。採取した血液サンプルは直ちに4℃にて2000rpmで1
0分間遠心分離して血漿を分取し、測定時まで凍結保存
した。血漿中のカテコールアミン類の測定は、除蛋白し
た血漿サンプルを、カテコール核と特異的に反応する蛍
光試薬であるジフェニルエチレンジアミンを用いるポス
トカラム蛍光反応HPLC法を用いて、カテコールアミン分
析計(東ソー、HLC-8030)で分析した。Under the subject's nose while resting,
Attached absorbent cotton impregnated with essential oil to smell the scent, 7
Five minutes later, 5 ml of blood was collected again to obtain a sample showing the scent. A blood collection tube containing ADTA.2NA was used for blood collection. The collected blood sample should be immediately
The plasma was collected by centrifugation for 0 minutes and stored frozen until the time of measurement. Catecholamines in plasma were measured using a post-column fluorescence reaction HPLC method using diphenylethylenediamine, a fluorescent reagent that specifically reacts with catechol nuclei, from a deproteinized plasma sample using a catecholamine analyzer (Tosoh, HLC- 8030).
【0044】結果を図5に示す。図から明らかなよう
に、香り提示前に比べて、ペッパー又はグレープフルー
ツの香りを嗅いだ後では、アドレナリンやノルアドレナ
リン等のカテコールアミン類が増加しており、これら香
料の香りが交感神経活動を活性化し、アドレナリンやノ
ルアドレナリン等のカテコールアミン類の分泌を促進す
ることが明らかとなった。FIG. 5 shows the results. As is clear from the figure, compared to before the scent presentation, after smelling the scent of pepper or grapefruit, catecholamines such as adrenaline and noradrenaline are increasing, the scent of these fragrances activates the sympathetic nerve activity, It has been clarified that the secretion of catecholamines such as adrenaline and noradrenaline is promoted.
【0045】実施例3.カテコールアミン類(ノルアド
レナリン)とカフェインとの相乗効果 6週齢ラットの皮下組織70mgにノルアドレナリン(0.5
μg/ml)を添加すると図6に示す如くカフェイン(1m
M)はそれ自身でも脱共役蛋白質−3の発現を高める
が、ノルアドレナリン(0.5μg/ml)とカフェイン(1m
M)を同時に添加すると相乗的に脱共役蛋白質−3の発
現が高まった。 Embodiment 3 FIG . Catecholamines (Norad
Synergistic effect of renalin and caffeine Noradrenaline (0.5
μg / ml), caffeine (1m
M) itself enhances uncoupling protein-3 expression, but noradrenaline (0.5 μg / ml) and caffeine (1 m
The simultaneous addition of M) synergistically increased the expression of uncoupling protein-3.
【0046】実施例4.連用テストによる痩身効果の検
証 後に記載する乳液(処方例5)の乳液を用いて、痩身効
果を確認した。20〜30歳の女性20名に、1ヶ月間、前記
乳液を朝晩毎日ボデイに使用してもらい、連用テスト前
後の体重、周囲(ウエスト、ヒップ9の変化を比較し
た。結果は次の表1の通りであった。 Embodiment 4 FIG . Examination of slimming effect by continuous test
The slimming effect was confirmed using the emulsion described after the proof (Formulation Example 5). Twenty women aged 20 to 30 years old were allowed to use the emulsion for a month on the body every day for one month, and the changes in body weight, circumference (waist, hips 9) before and after the continuous test were compared. The results are shown in Table 1 below. It was as follows.
【0047】[0047]
【表1】 表1から明らかな通り、連用後、体重、ウエスト長及び
ヒップ長が有意に減少しており、本発明の痩身効果が確
認された。[Table 1] As is clear from Table 1, the weight, waist length and hip length significantly decreased after continuous use, and the slimming effect of the present invention was confirmed.
【0048】製剤例 製剤例において%は質量%を意味する。フレグランス (1)アルコール 75% (2)精製水 残余 (3)ジプロピレングリコール 5% (4)本発明の香料 10% (5)酸化防止剤 適量 (6)グレープフルーツオイル 5% (7)色素 適量 (8)紫外線吸収剤 適量 Formulation Examples In the formulation examples,% means mass%. Fragrance (1) Alcohol 75% (2) Purified water residue (3) Dipropylene glycol 5% (4) Perfume of the present invention 10% (5) Antioxidant appropriate amount (6) Grapefruit oil 5% (7) Pigment appropriate amount ( 8) Suitable amount of UV absorber
【0049】ここで「フレグランス」とは、アルコール
(例えば、エチルアルコール)又は水性アルコールに本
発明のグレープフルーツオイルを溶解したものである。
フレグランスは、本発明のグレープフルーツオイル1〜
99質量%含有する。水とアルコールの配合比は、50:
50から0:100の範囲である。フレグランスは、溶解
剤、柔軟化剤、ヒューメクタン、濃化剤、静菌剤、また
はその他化粧品に通常用いられる材料を含有することが
出来る。通常の調香手段を用いて、本発明のグレープフ
ルーツオイルに調和する香料成分を更に添加して変調
し、保留性やこくなどを加えて仕上げたり、あるいはト
ップノート、ミドルノート、ラストノートを適当に組み
合わせて経時的にも魅力的な芳香を発する配合物を調製
することが出来る。Here, the “fragrance” is a substance obtained by dissolving the grapefruit oil of the present invention in alcohol (for example, ethyl alcohol) or aqueous alcohol.
Fragrance is the grapefruit oil 1 of the present invention
Contains 99% by mass. The mixing ratio of water and alcohol is 50:
The range is 50 to 0: 100. Fragrances can contain solubilizers, softeners, humectans, thickeners, bacteriostats, or other materials commonly used in cosmetics. Using ordinary flavoring means, further add a flavor component that is in harmony with the grapefruit oil of the present invention and modulate it, and finish by adding a retaining property or body, or properly add a top note, middle note, last note Combinations can be made into formulations that emit an attractive aroma over time.
【0050】たとえば、そのようにしてこれら交感神経
活性を示す精油を組み合わせた配合物の例が香料処方例
1に示す処方である。この処方香料の交感神経活動への
影響を比較した結果、高い交感神経活性化効果が認めら
れた(図4)。For example, an example of a combination of these essential oils exhibiting sympathetic activity is the formulation shown in Formulation Example 1. As a result of comparing the influence of the prescription flavor on the sympathetic nerve activity, a high sympathetic nerve activating effect was recognized (FIG. 4).
【0051】 [0051]
【0052】調合香料処方例2及び3 No. 香料名 処方例2 処方例3 (1)グレープフルーツオイル 10.0 5.0 (2)エストラゴンオイル 32.0 30.0 (3)フェンネルオイル 8.0 1.0 (4)ペッパーオイル 0.1 − (5)ヒソップオイル 0.1 − (6)ベルガモット 1.0 − (7)CIS-3-ヘキソノール 2.0 0.7 (8)Cis-3-ヘキセニルアセテート 1.0 0.3 (9)トリプラール 2.0 0.7 (10)トマトベース 3.0 1.0 (11)スチラリルアセテート 2.0 0.7 (12)リファロール 3.0 1.0 (13)キャロン 1.0 1.0 (14)リナロール 10.0 10.0 (15)ベンジルアセテート 1.0 1.0 (16)へディオン 0.5 0.5 (17)βイオノン 1.0 1.0 (18)メントール 10.0 10.0 (19)ムスク 1.0 5.0 (20)トリエチルシトレート 11.3 31.1 Formulation Examples 2 and 3 of Novel Flavor No. Formulation Example 2 Formulation Example 3 (1) Grapefruit oil 10.0 5.0 (2) Estragon oil 32.0 30.0 (3) Fennel oil 8.0 1.0 (4) Pepper oil 0.1-(5) ) Hyssop oil 0.1-(6) Bergamot 1.0-(7) CIS-3-hexonol 2.0 0.7 (8) Cis-3-hexenyl acetate 1.0 0.3 (9) Tripral 2.0 0.7 (10) Tomato base 3.0 1.0 (11) Styralyl Acetate 2.0 0.7 (12) Rifarol 3.0 1.0 (13) Caron 1.0 1.0 (14) Linalool 10.0 10.0 (15) Benzyl acetate 1.0 1.0 (16) Hedion 0.5 0.5 (17) β-ionone 1.0 1.0 (18) Menthol 10.0 10.0 ( 19) Musk 1.0 5.0 (20) Triethyl citrate 11.3 31.1
【0053】調合香料処方例4及び5 No. 香料名 処方例4 処方例5 (1)グレープフルーツオイル 200 200 (2)リナロール 20 20 (3)リナリルアセテート 10 20 (4)ペッパーオイル 100 20 (5)フェンネルオイル 20 10 (6)エストラゴンオイル 10 10 (7)セージオイル 20 20 (8)ヘリオナール 20 − (9)マンザネート 20 − (10)へディオン 150 150 (11)ジハイドロミルセノール 50 − (12)ガラクソライド 50 50 (13)ベルガモットオイル 50 50 (14)リモネン 140 140 (15)シス−3−ヘキセノール 1 − (16)ヘリオナール 2 − (17)アリルアミルグリコレート 2 − (18)α−ヘキシルシンナミックアルデヒド − 40 (19)フェニルエチルアルコール − 20 (20)リリアール − 20 (21)リラ−ル − 20 (22)β−イオノン − 20 (23)メチルイオノンγ − 30 (24)ゲラニオール − 30 (25)シトロネロール − 20 (26)ジメチルベンジルカルボニルアセテート − 50 (27)ジプロピレングリコール 135 70 合計 1,000 1,000 Formulation Examples 4 and 5 of Novel Flavor No. Formulation Example 4 Formulation Example 5 (1) Grapefruit oil 200 200 (2) Linalool 20 20 (3) Linalyl acetate 10 20 (4) Pepper oil 100 20 (5) Fennel oil 20 10 (6) Estragon oil 10 10 (7) Sage oil 20 20 (8) Helional 20-(9) Manzanate 20-(10) hedion 150 150 (11) Dihydromyrcenol 50-(12) Galaxolide 50 50 (13) bergamot oil 50 50 (14) limonene 140 140 (15) cis-3-hexenol 1- (16) helional 2- (17) allyl amyl glycolate 2- (18) α-hexylcinnamic aldehyde − 40 (19) Phenylethyl alcohol − 20 (20) Lilyal − 20 (21) Lylal − 20 (22) β-ionone − 20 (23) Methyl ion Emission gamma - 30 (24) Geraniol - 30 (25) Citronellol - 20 (26) dimethylbenzyl carbonyl acetate - 50 (27) Dipropylene glycol 135 70 Total 1,000 1,000
【0054】皮膚外用剤(化粧品) 薬剤としては、トリメチルグリシン、褐藻エキス、紅藻
エキス、緑藻エキス、酢酸トコフェロール、納豆エキ
ス、ドクダミエキスなどの各種エキスや、グリチルリチ
ン酸ジカリウムなどの皮膚外用薬に用いる事が出来る各
種薬剤を配合することが出来る。As an external preparation for skin (cosmetics), it is used for various extracts such as trimethylglycine, brown algae extract, red algae extract, green algae extract, tocopherol acetate, natto extract, dokudami extract, and external preparations for skin such as dipotassium glycyrrhizinate. Various drugs that can be used can be compounded.
【0055】化粧水(処方例1) (1)グリセリン 2% (2)ジプロピレングリコール 2% (3)PEG-60 水添ひまし油 0.3% (4)トリメチルグリシン 0.1% (5)防腐剤 適量 (6)キレート剤 適量 (7)染料 適量 (8)本発明香料 適量 (9)精製水 残量 Toner (Formulation Example 1) (1) Glycerin 2% (2) Dipropylene glycol 2% (3) PEG-60 hydrogenated castor oil 0.3% (4) Trimethylglycine 0.1% (5) Preservative (6) ) Chelating agent appropriate amount (7) dye appropriate amount (8) perfume of the present invention appropriate amount (9) purified water balance
【0056】化粧水(処方例2) (1)アルコール 30% (2)ブチレングリコール 4% (3)グリセリン 2% (4)PPG-13デシルテトラデス24 0.3% (5)オクチルメトキシシンナメート 0.1% (6)メントール 0.2% (7)酢酸トコフェロール 0.1% (8)キレート剤 適量 (9)染料 適量 (10)本発明の香料 適量 (11)精製水 残量 Lotion (Formulation Example 2) (1) Alcohol 30% (2) Butylene glycol 4% (3) Glycerin 2% (4) PPG-13 decyltetrades 24 0.3% (5) Octyl methoxycinnamate 0.1% (6) Menthol 0.2% (7) Tocopherol acetate 0.1% (8) Suitable amount of chelating agent (9) Suitable amount of dye (10) Suitable amount of fragrance of the present invention (11) Remaining amount of purified water
【0057】乳液(処方例1) (1)エチルアルコール 10% (2)シクロメチコン 0.1% (3)ブチレングリコール 5% (4)ジメチコン 3% (5)グリセリン 0.1% (6)メントール 1% (7)トリメチルシロキシケイ酸 0.1% (8)カフェイン 1% (9)トリメチルグリシン 1% (10)キサンタンガム 0.001% (11)ヒドロキシエチルセルロース 0.1% (12)大豆発酵エキス 1% (13)ラウリルベタイン 0.5% (14)褐藻エキス 1% (15)紅藻エキス 1% (16)緑藻エキス 1% (17)カルボマー 0.2% (18)キレート剤 適量 (19)パラベン 適量 (20)安息香酸 適量 (21)本発明の香料 適量 (22)酸化鉄 適量 (23)苛性カリ 0.05% (24)グリチルリチン酸ジカリウム 0.01% (25)塩酸ピリドキシン 0.01% (26)アスコルビン酸グルコシド 0.01% (27)アスコルビン酸 0.01% (28)アルブチン 3% (29)ユキノシタ抽出液 0.1% (30)水 残量 Emulsion (Formulation Example 1) (1) Ethyl alcohol 10% (2) Cyclomethicone 0.1% (3) Butylene glycol 5% (4) Dimethicone 3% (5) Glycerin 0.1% (6) Menthol 1% (7) ) Trimethylsiloxysilicate 0.1% (8) Caffeine 1% (9) Trimethylglycine 1% (10) Xanthan gum 0.001% (11) Hydroxyethylcellulose 0.1% (12) Soybean fermented extract 1% (13) Lauryl betaine 0.5% ( 14) Brown algae extract 1% (15) Red algae extract 1% (16) Green algae extract 1% (17) Carbomer 0.2% (18) Chelating agent appropriate amount (19) Paraben appropriate amount (20) Benzoic acid appropriate amount (21) The present invention Perfume Appropriate amount (22) Iron oxide Appropriate amount (23) Caustic potassium 0.05% (24) Dipotassium glycyrrhizinate 0.01% (25) Pyridoxine hydrochloride 0.01% (26) Glucos ascorbate 0.01% (27) 0.01% ascorbic acid (28) Arbutin 3% (29) Saxifraga extract 0.1% (30) Water Balance
【0058】乳液(処方例2) (1)ブチレングリコール 4% (2)プロピレングリコール 4% (3)カルボマー 0.2% (4)苛性カリ 0.2% (5)ベヘニン酸 0.5% (6)ステアリン酸 0.5% (7)イソステアリン酸 0.5% (8)ステアリン酸グリセリル 1% (9)イソステアリン酸グリセリル 1% (10)ベヘニルアルコール 0.5% (11)バチルアルコール 0.5% (12)スクワラン 5% (13)トリオクタノイン 3% (14)フェニルトリメチコン 2% (15)グリチルリチン酸ジカリウム 0.01% (16)防腐剤 適量 (17)キレート剤 適量 (18)顔料 適量 (19)本発明の香料 適量 (20)精製水 残量 Emulsion (Formulation Example 2) (1) Butylene glycol 4% (2) Propylene glycol 4% (3) Carbomer 0.2% (4) Caustic potassium 0.2% (5) Behenic acid 0.5% (6) Stearic acid 0.5% ( 7) Isostearic acid 0.5% (8) Glyceryl stearate 1% (9) Glyceryl isostearate 1% (10) Behenyl alcohol 0.5% (11) Bacyl alcohol 0.5% (12) Squalane 5% (13) Trioctanoin 3% ( 14) Phenyltrimethicone 2% (15) Dipotassium glycyrrhizinate 0.01% (16) Suitable amount of preservative (17) Suitable amount of chelating agent (18) Suitable amount of pigment (19) Suitable amount of fragrance of the present invention (20) Remaining amount of purified water
【0059】乳液(処方例3) (1)グリセリン 3% (2)キシリトール 2% (3)カルボマー 0.1% (4)苛性カリ 0.1% (5)イソステアリン酸グリセリル 1% (6)ステアリン酸グリセリル 0.5% (7)ベヘニルアルコール 1% (8)バチルアルコール 1% (9)パーム硬化油 2% (10)ワセリン 1% (11)スクワラン 5% (12)オクタン酸エリスリチル 3% (13)シクロメチコン 1% (14)防腐剤 適量 (15)キレート剤 適量 (16)本発明の香料 残量 (17)精製水 残量 (18)トラネキサム酸 1% (19)パントテニルエチルエーテル 0.5% (20)ニコチン酸アミド 0.1% (21)トレハロース 0.1% (22)ローズマリーエキス 0.1% (23)ビタミンA 0.1% (24)アスコルビン酸グリコシド 0.001% (25)キイチゴ抽出液 1% (26)オウゴン抽出液 0.001% (27)オウバク抽出液 0.01% Emulsion (Formulation Example 3) (1) Glycerin 3% (2) Xylitol 2% (3) Carbomer 0.1% (4) Caustic potassium 0.1% (5) Glyceryl isostearate 1% (6) Glyceryl stearate 0.5% ( 7) Behenyl alcohol 1% (8) Bacyl alcohol 1% (9) Hardened palm oil 2% (10) Vaseline 1% (11) Squalane 5% (12) Erythrityl octoate 3% (13) Cyclomethicone 1% (14) Preservative proper amount (15) Chelating agent proper amount (16) Perfume residual amount of the present invention (17) Purified water residual amount (18) Tranexamic acid 1% (19) Pantothenyl ethyl ether 0.5% (20) Nicotinamide 0.1% ( 21) Trehalose 0.1% (22) Rosemary extract 0.1% (23) Vitamin A 0.1% (24) Ascorbic acid glycoside 0.001% (25) Raspberry extract 1% (26) E Gon extract 0.001% (27) bark extract 0.01%
【0060】乳液(処方例4) (1)エタノール 2% (2)シクロメチコン 10% (3)グリセリン 5% (4)ジブチレングリコール 1% (5)ジメチコン 1% (6)コーンスターチ 4% (7)ミネラルオイル 2% (8)トリメチルシロキシケイ酸 5% (9)ポリエチレングリコール 3% (10)乳酸メンチル 0.1% (11)PEG-60水添ヒマシ油 1% (12)アミノプロピルジメチコン 1% (13)キサンタンガム 0.01% (14)酢酸トコフェロール 0.01% (15)カフェイン 0.1% (16)ヒアルロン酸ナトリウム 0.1% (17)キサンタンガム 0.01% (18)大豆発酵エキス 0.01% (19)ハマメリスエキス 0.01% (20)ドクダミエキス 0.01% (21)カルボマー 0.3% (22)アクリル酸メタクリル酸アルキル共重合体 0.2% (23)HEDTA 適量 (24)防腐剤 適量 (25)本発明の香料 適量 (26)顔料 適量 (27)苛性カリ 0.15% (28)アミノメチルプロパノール 0.05% (29)水 残量 Emulsion (Formulation Example 4) (1) Ethanol 2% (2) Cyclomethicone 10% (3) Glycerin 5% (4) Dibutylene glycol 1% (5) Dimethicone 1% (6) Corn starch 4% (7) ) Mineral oil 2% (8) Trimethylsiloxysilicic acid 5% (9) Polyethylene glycol 3% (10) Menthyl lactate 0.1% (11) PEG-60 hydrogenated castor oil 1% (12) Aminopropyl dimethicone 1% (13 ) Xanthan gum 0.01% (14) Tocopherol acetate 0.01% (15) Caffeine 0.1% (16) Sodium hyaluronate 0.1% (17) Xanthan gum 0.01% (18) Fermented soybean extract 0.01% (19) Hamamelis extract 0.01% (20) Dokudami extract 0.01% (21) Carbomer 0.3% (22) Alkyl acrylate alkyl methacrylate 0.2% (23) HEDTA appropriate amount (24) Preservative appropriate amount (25 ) Perfume of the present invention suitable amount (26) pigment proper amount (27) caustic potash 0.15% (28) aminomethylpropanol 0.05% (29) water remaining amount
【0061】乳液(処方例5) (1)エタノール 15% (2)シクロメチコン 6% (3)ブチレングリコール 0.5% (4)ジメチコン 1% (5)グリセリン 1% (6)ポリエチレングリコール 1 (7)乳酸メンチル 1% (8)メントール 0.1% (9)トリメチルシロキシケイ酸 1% (10)カフェイン 0.5% (11)トリメチルグリシン 0.1% (12)キサンタンガム 0.1% (13)ヒドロキシエチルセルロース 0.1% (14)大豆発酵エキス 0.01% (15)酢酸トコフェロール 0.05% (16)ラウリルベタイン 0.01% (17)褐藻エキス 0.01% (18)ドクダミエキス 0.01% (19)紅藻エキス 0.01% (20)緑藻エキス 0.01% (21)セルロース末 1% (22)イソステアリン酸PEG-60グリセリル 1% (23)イソステアリン酸 1% (24)カルボマー 0.1% (25)アクリル酸メタクリル酸アルキル共重合体 0.1% (26)EDTA 0.1% (27)メタリン酸ナトリウム 0.1% (28)フェノキシエタノール 0.2% (29)パラベン 0.2% (30)本発明の香料(調合香料処方例1) 0.45 (31)酸化鉄(赤) 0.02% (32)メンチルグリセリルエーテル 0.01% (33)水 残量 Emulsion (Formulation Example 5) (1) Ethanol 15% (2) Cyclomethicone 6% (3) Butylene glycol 0.5% (4) Dimethicone 1% (5) Glycerin 1% (6) Polyethylene glycol 1 (7) Menthyl lactate 1% (8) Menthol 0.1% (9) Trimethylsiloxysilicic acid 1% (10) Caffeine 0.5% (11) Trimethylglycine 0.1% (12) Xanthan gum 0.1% (13) Hydroxyethyl cellulose 0.1% (14) Soy Fermented extract 0.01% (15) Tocopherol acetate 0.05% (16) Lauryl betaine 0.01% (17) Brown alga extract 0.01% (18) Dokudami extract 0.01% (19) Red algae extract 0.01% (20) Green algae extract 0.01% (21) Cellulose powder 1% (22) PEG-60 glyceryl isostearate 1% (23) Isostearic acid 1% (24) Carbomer 0.1% (25) Acrylic acid Alkyl acrylate copolymer 0.1% (26) EDTA 0.1% (27) Sodium metaphosphate 0.1% (28) Phenoxyethanol 0.2% (29) Paraben 0.2% (30) Fragrance of the present invention (Preparation example of compounded fragrance 1) 0.45 ( 31) Iron oxide (red) 0.02% (32) Menthyl glyceryl ether 0.01% (33) Water remaining
【0062】クリーム(処方例1) (1)グリセリン 10% (2)ブチレングリコール 5% (3)カルボマー 0.1% (4)苛性カリ 0.2% (5)ステアリン酸 2% (6)ステアリン酸グリセリル 2% (7)イソステアリン酸グリセリル 2% (8)ワセリン 5% (9)ステアリルアルコール 2% (10)ベヘニルアルコール 2% (11)パーム硬化油 2% (12)スクワラン 10% (13)4−メトキシカリチル酸K 3.0% (14)防腐剤 適量 (15)キレート剤 適量 (16)顔料 適量 (17)本発明の香料 適量 (18)精製水 残量 Cream (Formulation Example 1) (1) Glycerin 10% (2) Butylene glycol 5% (3) Carbomer 0.1% (4) Caustic potash 0.2% (5) Stearic acid 2% (6) Glyceryl stearate 2% ( 7) Glyceryl isostearate 2% (8) Vaseline 5% (9) Stearyl alcohol 2% (10) Behenyl alcohol 2% (11) Hardened palm oil 2% (12) Squalane 10% (13) 4-Methoxycalicylate 3.0% (14) Preservative appropriate amount (15) Chelating agent appropriate amount (16) Pigment appropriate amount (17) Perfume of the present invention appropriate amount (18) Purified water balance
【0063】クリーム(処方例2) (1)グリセリン 3% (2)ジプロピレングリコール 7% (3)ポリエチレングリコール 3% (4)ステアリン酸グリセリル 3% (5)イソステアリン酸グリセリル 2% (6)ステアリルアルコール 2% (7)ベヘニルアルコール 2% (8)流動パラフィン 7% (9)シクロメチコン 3% (10)ジメチコン 1% (11)オクチルメトキシシンナメート 0.1% (12)ヒアルロン酸Na 0.05% (13)防腐剤 適量 (14)キレート剤 適量 (15)顔料 適量 (16)本発明の香料 適量 (17)精製水 残量 Cream (Formulation Example 2) (1) Glycerin 3% (2) Dipropylene glycol 7% (3) Polyethylene glycol 3% (4) Glyceryl stearate 3% (5) Glyceryl isostearate 2% (6) Stearyl Alcohol 2% (7) Behenyl alcohol 2% (8) Liquid paraffin 7% (9) Cyclomethicone 3% (10) Dimethicone 1% (11) Octyl methoxycinnamate 0.1% (12) Na hyaluronate 0.05% (13) Preservative (14) Chelating agent (15) Pigment (16) Perfume of the present invention (17) Purified water
【0064】ジェル (1)エチルアルコール 10% (2)グリセリン 5% (3)ブチレングリコール 5% (4)カルボマー 0.5% (5)アミノメチルプロパノール 0.3% (6)PEG-60水添ひまし油 0.3% (7)メントール 0.02% (8)防腐剤 適量 (9)キレート剤 適量 (10)本発明の香料 適量 (11)精製水 残量 Gel (1) Ethyl alcohol 10% (2) Glycerin 5% (3) Butylene glycol 5% (4) Carbomer 0.5% (5) Aminomethylpropanol 0.3% (6) PEG-60 hydrogenated castor oil 0.3% ( 7) Menthol 0.02% (8) Preservative proper amount (9) Chelating agent proper amount (10) Perfume proper amount of the present invention (11) Purified water balance
【0065】エアゾール(処方例1) (1)グリセリン 2% (2)ジプロピレングリコール 2% (3)PEG-60水添ひまし油 0.3% (4)HPPCD (ヒドロキシプロピルβシクロデキストリン) 1.0% (5)防腐剤 適量 (6)キレート剤 適量 (7)染料 適量 (8)本発明の香料 適量 (9)精製水 残量 (10)窒素ガス 0.8% Aerosol (Formulation Example 1) (1) Glycerin 2% (2) Dipropylene glycol 2% (3) PEG-60 hydrogenated castor oil 0.3% (4) HPPCD (hydroxypropyl β-cyclodextrin) 1.0% (5) Preservative appropriate amount (6) Chelating agent appropriate amount (7) Dye appropriate amount (8) Flavor of the present invention appropriate amount (9) Purified water balance (10) Nitrogen gas 0.8%
【0066】エアゾール(処方例2) (1)アルコール 15% (2)ブチレングリコール 2% (3)グリセリン 1% (4)PPG-13 デシルテトラデス24 0.1% (5)銀担持ゼオライト末 1.0% (6)キレート剤 適量 (7)染料 適量 (8)本発明の香料 適量 (9)精製水 残量 (10)LPG 40% Aerosol (Formulation Example 2) (1) Alcohol 15% (2) Butylene glycol 2% (3) Glycerin 1% (4) PPG-13 decyltetrades 24 0.1% (5) Silver-loaded zeolite powder 1.0% ( 6) Suitable amount of chelating agent (7) Suitable amount of dye (8) Suitable amount of perfume of the present invention (9) Remaining amount of purified water (10) LPG 40%
【0067】エアゾール(処方例3) (1)エタノール 60% (2)乳酸メンチル 0.1% (3)乳酸ナトリウム 0.1% (4)酢酸トコフェロール 0.01% (5)乳酸 0.01% (6)カフェイン 0.01% (7)ウイキョウエキス 1% (8)ハマメリスエキス 1% (9)ドクダミエキス 1% (10)ジプロピレングリコール 1% (11)窒素ガス 0.9 (12)ポリオキシエチレンポリオキシプロピレン デシルテトラデシルエーテル 1% (13)ブチレングリコール 2% (14)トコフェロール 0.05% (15)本発明の香料 適量 (16)PEG-60水添ヒマシ油 0.1% (17)水 残量 Aerosol (Formulation Example 3) (1) Ethanol 60% (2) Menthyl lactate 0.1% (3) Sodium lactate 0.1% (4) Tocopherol acetate 0.01% (5) Lactic acid 0.01% (6) Caffeine 0.01% ( 7) Fennel extract 1% (8) Hamamelis extract 1% (9) Dokudami extract 1% (10) Dipropylene glycol 1% (11) Nitrogen gas 0.9 (12) Polyoxyethylene polyoxypropylene decyl tetradecyl ether 1% ( 13) Butylene glycol 2% (14) Tocopherol 0.05% (15) Appropriate amount of fragrance of the present invention (16) PEG-60 hydrogenated castor oil 0.1% (17) Water remaining amount
【0068】入浴剤 (1)硫酸ナトリウム 45.0% (2)炭酸水素ナトリウム 45.0% (3)ヒソップオイル 10.0% (4)本発明香料 適量 Bath agent (1) Sodium sulfate 45.0% (2) Sodium bicarbonate 45.0% (3) Hyssop oil 10.0% (4) Perfume of the present invention
【0069】ルームフレグランス (1)アルコール 80.0% (2)精製水 残余 (3)酸化防止剤 5.0% (4)本発明の香料 適量 (5)3−メチル−3メトキシブタノール 5.0% (6)ジベンジリデンソルビトール 5.0% (7)セージオイル 5.0% Room fragrance (1) Alcohol 80.0% (2) Purified water residue (3) Antioxidant 5.0% (4) Appropriate amount of perfume of the present invention (5) 3-Methyl-3-methoxybutanol 5.0% (6) Dibenzylidene Sorbitol 5.0% (7) Sage oil 5.0%
【0070】インセンス (1)タブ粉 75.5% (2)安息香酸ナトリウム 15.5% (3)本発明の香料 適量 (4)ユーカリオイル 1.0% (5)フェンネルオイル 1.0% (6)精製水 残余[0070] Incense (1) tab powder 75.5% (2) Sodium benzoate 15.5% (3) Perfume Appropriate amount (4) 1.0% eucalyptus oil of the present invention (5) Fennel oil 1.0% (6) Purified water Balance
【0071】マッサージ用ジェル (1)エリスリトール 2.0% (2)カフェイン 5.0% (3)オウバク抽出物 3.0% (4)グリセリン 50.0% (5)カルポキシビニルポリマー 0.40% (6)ポリエチレングリコール400 30.0% (7)エチレンジアミンヒドロキシエチル 三酢酸3ナトリウム 0.1% (8)ポリオキシエチレン(10)メチルポリシロキサン共重合体 2.0% (9)スクワラン 1.0% (10)フェンネルオイル 1.0% (11)水酸化カリウム 0.15% (12)精製水 残余 Massage gel (1) Erythritol 2.0% (2) Caffeine 5.0% (3) Ouba extract 3.0% (4) Glycerin 50.0% (5) Carboxy vinyl polymer 0.40% (6) Polyethylene glycol 400 30.0% (7) Ethylenediaminehydroxyethyl trisodium triacetate 0.1% (8) Polyoxyethylene (10) methylpolysiloxane copolymer 2.0% (9) Squalane 1.0% (10) Fennel oil 1.0% (11) Potassium hydroxide 0.15% (12) Purified water residue
【0072】フォームパック (1)カフェイン 1.0% (2)メタリン酸ナトリウム 0.02% (3)トレハロース 2.0% (4)グリセリン 7.0% (5)メチルパラベン 0.11% (6)水酸化カリウム 0.15% (7)ステアリン酸 0.5% (8)ミリスチン酸 1.0% (9)バチルアルコール 1.5% (10)ポリオキシエチレン(60)硬化ヒマシ油 3.0% (11)ペッパーオイル 0.3% (12)液化石油ガス 6.0% (13)ジメチルエーテル 3.0% (14)本発明香料 適量 (15)精製水 残余 Foam pack (1) Caffeine 1.0% (2) Sodium metaphosphate 0.02% (3) Trehalose 2.0% (4) Glycerin 7.0% (5) Methyl paraben 0.11% (6) Potassium hydroxide 0.15% (7) Stearin Acid 0.5% (8) Myristic acid 1.0% (9) Bacyl alcohol 1.5% (10) Polyoxyethylene (60) Hardened castor oil 3.0% (11) Pepper oil 0.3% (12) Liquefied petroleum gas 6.0% (13) Dimethyl ether 3.0% (14) Appropriate amount of the fragrance of the present invention (15) Residual water
【0073】[0073]
【発明の効果】本発明によれば、副作用の無い交感神経
活性化組成物を提供することが出来、さらには、痩身用
組成物、記憶力向上組成物を提供する。According to the present invention, a sympathetic nerve activating composition having no side effects can be provided, and further, a slimming composition and a memory improving composition are provided.
【図1】図1は、収縮期血圧変動解析による交感神経相
対活性を示すグラフである。FIG. 1 is a graph showing sympathetic nerve relative activity by systolic blood pressure fluctuation analysis.
【図2】図2は、収縮期血圧変動解析による交感神経相
対活性を示すグラフである。FIG. 2 is a graph showing sympathetic nerve relative activity by systolic blood pressure fluctuation analysis.
【図3】図3は、ペッパーの熱水抽出物の交感神経相対
活性を示すグラフである。FIG. 3 is a graph showing the sympathetic relative activity of a hot water extract of pepper.
【図4】図4は、交感神経を活性化させる効果のある精
油を組み合わせた配合物(香料処方1)の、交感神経相
対活性を示すグラフである。FIG. 4 is a graph showing the sympathetic nerve relative activity of a formulation (perfume formulation 1) in which essential oil having an effect of activating the sympathetic nerve is combined.
【図5】図5は、交感神経活性化香料の香りによる血中
カテコールアミン類の増加を示すグラフである。FIG. 5 is a graph showing an increase in catecholamines in blood due to the aroma of a sympathetic nerve activating fragrance.
【図6】図6は、皮下脂肪組織における脱共役蛋白質−
3の遺伝子の発現に対するカフェイン及びノルアドレナ
リンの相乗効果を示すグラフである。FIG. 6 shows uncoupling protein in subcutaneous adipose tissue.
3 is a graph showing the synergistic effect of caffeine and noradrenaline on the expression of 3 genes.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 7/00 A61K 7/00 N 4H059 R S U 7/46 7/46 A 7/48 7/48 7/50 7/50 31/01 31/01 31/015 31/015 31/235 31/235 31/522 31/522 35/78 35/78 C K N Q T A61P 3/04 A61P 3/04 17/00 17/00 25/02 104 25/02 104 25/28 25/28 43/00 111 43/00 111 // A23L 1/22 A23L 1/22 C 1/221 1/221 C (72)発明者 合津 陽子 神奈川県横浜市都筑区早渕2−2−1 株 式会社資生堂リサーチセンター(新横浜) 内 (72)発明者 小泉 祐貴子 神奈川県横浜市都筑区早渕2−2−1 株 式会社資生堂リサーチセンター(新横浜) 内 Fターム(参考) 4B047 LB03 LB08 LB09 LG05 LG11 LG12 LG37 LP01 4C083 AA032 AA112 AA121 AA122 AB032 AB082 AB232 AB282 AB312 AB352 AB442 AC011 AC012 AC022 AC031 AC032 AC072 AC102 AC112 AC122 AC132 AC172 AC242 AC262 AC302 AC312 AC341 AC342 AC422 AC432 AC442 AC482 AC532 AC542 AC582 AC622 AC642 AC712 AC851 AC852 AC912 AD042 AD092 AD152 AD172 AD212 AD242 AD262 AD282 AD332 AD352 AD392 AD532 AD622 AD642 AD662 CC04 CC05 CC07 CC50 DD08 DD23 DD27 DD31 DD41 EE06 EE41 EE50 4C086 AA01 AA02 CB07 MA01 MA02 MA03 MA04 MA07 MA09 MA63 NA14 ZA15 ZA25 ZA70 ZA89 ZC02 ZC21 4C088 AB12 AB26 AB33 AB38 AB40 AB55 AB57 AB62 AB81 AC01 AC03 AC04 AC05 AC06 AC11 AC12 BA08 CA15 MA07 MA63 NA14 ZA15 ZA25 ZA70 ZA89 ZC02 ZC21 4C206 AA01 AA02 BA02 BA03 KA01 KA08 MA01 MA02 MA03 MA04 MA11 MA17 MA83 NA14 ZA15 ZA25 ZA70 ZA89 ZC02 ZC21 4H059 BA01 BA02 BA35 BA52 BB05 BB06 BB13 BB14 BB15 BB18 BB19 BB24 BB44 BB45 BC23 DA09 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) A61K 7/00 A61K 7/00 N 4H059 R SU 7/46 7/46 A 7/48 7/48 7 / 50 7/50 31/01 31/01 31/015 31/015 31/235 31/235 31/522 31/522 35/78 35/78 CK N Q T A61P 3/04 A61P 3/04 17 / 00 17/00 25/02 104 25/02 104 25/28 25/28 43/00 111 43/00 111 // A23L 1/22 A23L 1/22 C 1/221 1/221 C (72) Inventor Aizu Yoko 2-2-1 Hayabuchi, Tsuzuki-ku, Yokohama-shi, Kanagawa Prefecture Inside Shiseido Research Center (Shin-Yokohama) (72) Inventor Yukiko Koizumi 2-2-1 Hayabuchi, Tsuzuki-ku, Yokohama-shi, Kanagawa Shiseido Research Center (Shin-Yokohama) ) F term (reference) 4B047 LB03 LB08 LB09 LG05 LG11 LG12 LG37 LP01 4C083 AA032 A A112 AA121 AA122 AB032 AB082 AB232 AB282 AB312 AB352 AB442 AC011 AC012 AC022 AC031 AC032 AC072 AC102 AC112 AC122 AC132 AC172 AC242 AC262 AC302 AC312 AC341 AC342 AC422 AC432 AC442 AC482 AC532 AC542 AC582 AC622 AC642 AC712 AC851 AC852 AD912 AD332 AD212 AD212 AD12 AD392 AD532 AD622 AD642 AD662 CC04 CC05 CC07 CC50 DD08 DD23 DD27 DD31 DD41 EE06 EE41 EE50 4C086 AA01 AA02 CB07 MA01 MA02 MA03 MA04 MA07 MA09 MA63 NA14 ZA15 ZA25 ZA70 ZA89 ZC02 ZC21 4C088 AB12 AB26 AC33 AB38 AB36 AC11 AC12 BA08 CA15 MA07 MA63 NA14 ZA15 ZA25 ZA70 ZA89 ZC02 ZC21 4C206 AA01 AA02 BA02 BA03 KA01 KA08 MA01 MA02 MA03 MA04 MA11 MA17 MA83 NA14 ZA15 ZA25 ZA70 ZA89 ZC02 ZC21 4H059 BA01 BB05 BB15 BB52 BB15 BB52 DA09
Claims (11)
イル、ペッパーオイル、ヒソップオイル、セージオイ
ル、エストラゴンオイル、ユーカリオイル、ローズマリ
ーオイル、シンナモンオイル、クローブオイル、イラン
イランオイル、ジンジャーオイル、ゼラニウムオイル及
びオリバナムより選ばれる1種または2種以上を含有する
ことを特徴とする交感神経活性化香料組成物。1. Select from fennel oil, grapefruit oil, pepper oil, hyssop oil, sage oil, estragon oil, eucalyptus oil, rosemary oil, cinnamon oil, clove oil, ylang ylang oil, ginger oil, geranium oil and oribanam A sympathetic nerve activating fragrance composition comprising one or more of the above.
ルベンゾエートより選ばれる1種又は2種以上を含有す
ることを特徴とする交感神経活性化香料組成物。2. A sympathetic nerve activating fragrance composition comprising one or more selected from limonene, pinene, myrcene and benzyl benzoate.
香料組成物を有効成分として含むことを特徴とする皮膚
外用剤組成物または雑貨類。3. A skin external preparation composition or miscellaneous goods comprising the sympathetic nerve activating fragrance composition according to claim 1 or 2 as an active ingredient.
イル、ペッパーオイル、ヒソップオイル、セージオイ
ル、エストラゴンオイル、ユーカリオイル、ローズマリ
ーオイル、シンナモンオイル、クローブオイル、イラン
イランオイル、ジンジャーオイル、ゼラニウムオイル及
びオリバナムより選ばれる1種又は2種以上を含有するこ
とを特徴とする痩身用香料組成物。4. A material selected from fennel oil, grapefruit oil, pepper oil, hyssop oil, sage oil, estragon oil, eucalyptus oil, rosemary oil, cinnamon oil, clove oil, ylang ylang oil, ginger oil, geranium oil and oribanam. A slimming fragrance composition comprising one or more of the above.
ルベンゾエートより選ばれる1種又は2種以上を含有す
ることを特徴とする痩身用香料組成物。5. A slimming fragrance composition comprising one or more selected from limonene, pinene, myrcene and benzyl benzoate.
イル、ペッパーオイル、ヒソップオイル、セージオイ
ル、エストラゴンオイル、ユーカリオイル、ローズマリ
ーオイル、シンナモンオイル、クローブオイル、イラン
イランオイル、ジンジャーオイル、ゼラニウムオイル及
びオリバナムより選ばれる1種又は2種以上を含有するこ
とを特徴とする記憶力向上香料組成物。6. Selected from fennel oil, grapefruit oil, pepper oil, hyssop oil, sage oil, estragon oil, eucalyptus oil, rosemary oil, cinnamon oil, clove oil, ylang ylang oil, ginger oil, geranium oil and oribanam. A fragrance composition for improving memory ability, comprising one or more of the above.
ルベンゾエートより選ばれる1種又は2種以上を含有す
ることを特徴とする記憶力向上香料組成物。7. A memory enhancing fragrance composition comprising one or more selected from limonene, pinene, myrcene and benzyl benzoate.
イル、ペッパーオイル、ヒソップオイル、セージオイ
ル、エストラゴンオイル、ユーカリオイル、ローズマリ
ーオイル、シンナモンオイル、クローブオイル、イラン
イランオイル、ジンジャーオイル、ゼラニウムオイル及
びオリバナムより選ばれる1種又は2種以上をかがせるこ
とを特徴とする痩身方法。8. A material selected from fennel oil, grapefruit oil, pepper oil, hyssop oil, sage oil, estragon oil, eucalyptus oil, rosemary oil, cinnamon oil, clove oil, ylang ylang oil, ginger oil, geranium oil and oribanam. Slimming method characterized by bending one or more kinds of slimming.
ルベンゾエートより選ばれる1種又は2種以上をかがせ
ることを特徴とする痩身方法。9. A slimming method characterized by bending one or more selected from limonene, pinene, myrcene and benzyl benzoate.
化香料組成物を有効成分として含有することを特徴とす
る痩身用組成物。10. A slimming composition comprising the sympathetic nerve activating fragrance composition according to claim 1 or 2 as an active ingredient.
とする請求項10に記載の痩身用組成物。11. The slimming composition according to claim 10, further comprising caffeine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001390141A JP2002265977A (en) | 2000-12-25 | 2001-12-21 | Perfume composition capable of activating sympathetic nerve |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000393457 | 2000-12-25 | ||
JP2000-393457 | 2000-12-25 | ||
JP2001390141A JP2002265977A (en) | 2000-12-25 | 2001-12-21 | Perfume composition capable of activating sympathetic nerve |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004336545A Division JP2005047935A (en) | 2000-12-25 | 2004-11-19 | Slimming composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2002265977A true JP2002265977A (en) | 2002-09-18 |
Family
ID=26606569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001390141A Pending JP2002265977A (en) | 2000-12-25 | 2001-12-21 | Perfume composition capable of activating sympathetic nerve |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2002265977A (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005187432A (en) * | 2003-12-26 | 2005-07-14 | Shiseido Co Ltd | Composition for inhibiting fat accumulation |
JP2005330252A (en) * | 2004-05-21 | 2005-12-02 | Pokka Corp | Brain function promoting agent |
JP2006137707A (en) * | 2004-11-12 | 2006-06-01 | Shiseido Co Ltd | Fragrance composition for male hormone adjustment |
WO2007026645A1 (en) * | 2005-08-31 | 2007-03-08 | Nature Technology Inc. | Dieting composition comprising plant-derived essential oil as active ingredient, sheet-type dieting composition comprising the composition, transdermal pharmaceutical preparation for dieting, and methods for production of the preparation |
JP2007302572A (en) * | 2006-05-09 | 2007-11-22 | Pokka Corp | Brain function improver and brain function-improving composition containing the same |
JP2008255060A (en) * | 2007-04-05 | 2008-10-23 | Hakugen:Kk | Bath agent and method for bathing by using the same |
WO2010041410A1 (en) * | 2008-10-08 | 2010-04-15 | 江隈親司 | Agent for suppressing increases in cholesterol |
JP2010241792A (en) * | 2009-03-19 | 2010-10-28 | Shiratori Pharmaceutical Co Ltd | Lipase inhibitor, and food and drink |
JP2010254704A (en) * | 2003-09-05 | 2010-11-11 | Shiseido Co Ltd | Composition for reducing sebum amount, article for reducing sebum amount, and beauty regimen using the same |
JP2012012385A (en) * | 2010-05-31 | 2012-01-19 | Shiseido Co Ltd | Sympathetic nerve activator, and cosmetic, food and sundries containing the same |
JP2016538274A (en) * | 2013-10-31 | 2016-12-08 | アロマスティック アーゲー | Composition used for inhalation device and inhalation device usable for that purpose |
KR102538787B1 (en) * | 2022-04-27 | 2023-06-01 | 주식회사 빅썸바이오 | Composition for enhancing awakening and concentration of human brain and uses thereof |
-
2001
- 2001-12-21 JP JP2001390141A patent/JP2002265977A/en active Pending
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010254704A (en) * | 2003-09-05 | 2010-11-11 | Shiseido Co Ltd | Composition for reducing sebum amount, article for reducing sebum amount, and beauty regimen using the same |
JP2005187432A (en) * | 2003-12-26 | 2005-07-14 | Shiseido Co Ltd | Composition for inhibiting fat accumulation |
JP2005330252A (en) * | 2004-05-21 | 2005-12-02 | Pokka Corp | Brain function promoting agent |
JP2006137707A (en) * | 2004-11-12 | 2006-06-01 | Shiseido Co Ltd | Fragrance composition for male hormone adjustment |
WO2007026645A1 (en) * | 2005-08-31 | 2007-03-08 | Nature Technology Inc. | Dieting composition comprising plant-derived essential oil as active ingredient, sheet-type dieting composition comprising the composition, transdermal pharmaceutical preparation for dieting, and methods for production of the preparation |
JP2007302572A (en) * | 2006-05-09 | 2007-11-22 | Pokka Corp | Brain function improver and brain function-improving composition containing the same |
JP2008255060A (en) * | 2007-04-05 | 2008-10-23 | Hakugen:Kk | Bath agent and method for bathing by using the same |
WO2010041410A1 (en) * | 2008-10-08 | 2010-04-15 | 江隈親司 | Agent for suppressing increases in cholesterol |
JP2010241792A (en) * | 2009-03-19 | 2010-10-28 | Shiratori Pharmaceutical Co Ltd | Lipase inhibitor, and food and drink |
JP2012012385A (en) * | 2010-05-31 | 2012-01-19 | Shiseido Co Ltd | Sympathetic nerve activator, and cosmetic, food and sundries containing the same |
JP2016538274A (en) * | 2013-10-31 | 2016-12-08 | アロマスティック アーゲー | Composition used for inhalation device and inhalation device usable for that purpose |
KR102538787B1 (en) * | 2022-04-27 | 2023-06-01 | 주식회사 빅썸바이오 | Composition for enhancing awakening and concentration of human brain and uses thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1346726A1 (en) | Sympathetic-activating perfume composition | |
Prusinowska et al. | Composition, biological properties and therapeutic effects of lavender (Lavandula angustifolia L.). A review | |
Chu et al. | Lavender (Lavandula spp.) | |
KR101077018B1 (en) | Cosmetic Composition with Anti-stress and Relaxing Effect | |
KR20120131970A (en) | Perfume composition with antistress and relexing effect, and cosmetic composition comprising the same | |
JP2009235015A (en) | Autonomic nerve regulator | |
JP2002265977A (en) | Perfume composition capable of activating sympathetic nerve | |
KR20210030166A (en) | Aroma scrub pack composition containing natural essential oil and seed oil processing by-products and method for producing the same | |
Kozak et al. | Health properties of selected herbal plants | |
KR101434449B1 (en) | Natural Fragrance Composition Displaying Anti-tress Using an Essential Oil Extract of Torreya nucifera Leaf | |
Prosche et al. | Flower power: an overview on chemistry and biological impact of selected essential oils from blossoms | |
KR101729921B1 (en) | Aromatheraphy mist composition with natural essential and natural hydrosol | |
KR102309548B1 (en) | Functional Face Oil Compostion Containg Aromatic Natural Essential Oil and Seed Oil | |
Valnet | Essential oils & aromatherapy | |
KR20220086434A (en) | Aromatic composition containing extract of rosa hybrid and extract of camellia japonica flower for psychological relaxation | |
KR102814814B1 (en) | Aromatherapy composition for psychological stability and cellulite reduction and manufacturingmethod thereof | |
KR101490114B1 (en) | Perfume Composition Using an Essential Oil Extract of Acorus gramineus and an Essential Oil Extract of Torreya nucifera | |
CN116869884A (en) | Composition containing lemon peel extract and preparation method and application thereof | |
Chinnappan et al. | Natural essential oils for antiaging: A review | |
JP2005047935A (en) | Slimming composition | |
Bhavani et al. | Formulation and evaluation of herbal soap by using natural ingredient | |
JP2014005403A (en) | Perfume composition and cosmetics | |
JPH11343497A (en) | Cosmetic | |
Keller | Aromatherapy Handbook for Beauty, Hair, and Skin Care | |
CA1276888C (en) | Method of causing the reduction of physiological and/or subjective reactivity to stress in humans being subjected to stress conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20040909 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040921 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041119 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070220 |